Micron Technology (MU) 10-K 4 Oct 24 2024 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
	Aug. 29, 2024	Sep. 27, 2024	Feb. 29, 2024
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Aug. 29, 2024
Document Transition Report	false
Entity File Number	1-10658
Entity Registrant Name	Micron Technology, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	75-1618004
Entity Address, Address Line One	8000 S. Federal Way
Entity Address, City or Town	Boise
Entity Address, State or Province	ID
Entity Address, Postal Zip Code	83716
City Area Code	208
Local Phone Number	368-4000
Title of 12(b) Security	Common Stock, par value $0.10 per share
Trading Symbol	MU
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction	false
Entity Shell Company	false
Entity Public Float			$ 83.6
Entity Common Stock, Shares Outstanding		1,108,742,682
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE Portions of the Proxy Statement for the registrant’s Fiscal 2024 Annual Meeting of Shareholders to be held on January 16, 2025 are incorporated by reference into Part III of this Annual Report on Form 10-K.
Entity Central Index Key	0000723125
Current Fiscal Year End Date	--08-29
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
	Aug. 29, 2024
Audit Information [Abstract]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	San Jose, California
Auditor Firm ID	238

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Income Statement [Abstract]
Revenue	$ 25,111	$ 15,540	$ 30,758
Cost of goods sold	19,498	16,956	16,860
Gross margin	5,613	(1,416)	13,898
Research and development	3,430	3,114	3,116
Selling, general, and administrative	1,129	920	1,066
Restructure and asset impairments	1	171	48
Other operating (income) expense, net	(251)	124	(34)
Operating income (loss)	1,304	(5,745)	9,702
Interest income	529	468	96
Interest expense	(562)	(388)	(189)
Other non-operating income (expense), net	(31)	7	(38)
Income (loss) before income taxes and equity in net income (loss) of equity method investees	1,240	(5,658)	9,571
Income tax (provision) benefit	(451)	(177)	(888)
Equity in net income (loss) of equity method investees	(11)	2	4
Net income (loss)	$ 778	$ (5,833)	$ 8,687
Earnings (loss) per share
Basic (in dollars per share)	$ 0.70	$ (5.34)	$ 7.81
Diluted (in dollars per share)	$ 0.70	$ (5.34)	$ 7.75
Number of shares used in per share calculations
Basic (in shares)	1,105	1,093	1,112
Diluted (in shares)	1,118	1,093	1,122

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 778	$ (5,833)	$ 8,687
Other comprehensive income (loss), net of tax
Gains (losses) on derivative instruments	142	234	(516)
Unrealized gains (losses) on investments	33	6	(48)
Pension liability adjustments	3	11	3
Foreign currency translation adjustments	0	(3)	(1)
Other comprehensive income (loss)	178	248	(562)
Total comprehensive income (loss)	$ 956	$ (5,585)	$ 8,125

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions		Aug. 29, 2024	Aug. 31, 2023
Assets
Cash and equivalents		$ 7,041	$ 8,577
Short-term investments		1,065	1,017
Receivables		6,615	2,443
Inventories		8,875	8,387
Other current assets		776	820
Total current assets		24,372	21,244
Long-term marketable investments	[1]	1,046	844
Property, plant, and equipment		39,749	37,928
Operating lease right-of-use assets		645	666
Intangible assets		416	404
Deferred tax assets		520	756
Goodwill		1,150	1,150
Other noncurrent assets		1,518	1,262
Total assets		69,416	64,254
Liabilities and equity
Accounts payable and accrued expenses		7,299	3,958
Current debt		431	278
Other current liabilities		1,518	529
Total current liabilities		9,248	4,765
Long-term debt		12,966	13,052
Noncurrent operating lease liabilities		610	603
Noncurrent unearned government incentives		550	727
Other noncurrent liabilities		911	987
Total liabilities		24,285	20,134
Commitments and contingencies
Shareholders’ equity
Common stock, $0.10 par value, 3,000 shares authorized, 1,253 shares issued and 1,109 outstanding (1,239 shares issued and 1,098 outstanding as of August 31, 2023)		125	124
Additional capital		12,115	11,036
Retained earnings		40,877	40,824
Treasury stock, 144 shares held (141 shares as of August 31, 2023)		(7,852)	(7,552)
Accumulated other comprehensive income (loss)		(134)	(312)
Total equity		45,131	44,120
Total liabilities and equity		$ 69,416	$ 64,254
[1] The maturities of long-term marketable investments primarily range from one five years, except for asset-backed securities which are not due at a single maturity date.

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares shares in Millions	Aug. 29, 2024	Aug. 31, 2023
Shareholders’ equity
Common Stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common Stock, authorized shares (in shares)	3,000	3,000
Common Stock, issued (in shares)	1,253	1,239
Common Stock, outstanding (in shares)	1,109	1,098
Treasury Stock, held (in shares)	144	141

STATEMENT OF CHANGES IN EQUITY

STATEMENT OF CHANGES IN EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Balance (in shares) at Sep. 02, 2021		1,216
Balance of total equity at Sep. 02, 2021	$ 43,933	$ 122	$ 9,453	$ 39,051	$ (4,695)	$ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	8,687			8,687
Other comprehensive income (loss), net	(562)					(562)
Stock issued under equity compensation plans (in shares)		12
Stock issued under equity compensation plans	245	$ 1	244
Stock-based compensation expense	514		514
Repurchase of stock - repurchase program	(2,432)				(2,432)
Repurchase of stock - withholdings on employee equity awards (in shares)		(2)
Repurchase of stock - withholdings on employee equity awards	$ (126)	$ 0	(14)	(112)
Dividends and dividend equivalents declared (per share)	$ 0.315
Dividends and dividend equivalents declared	$ (352)			(352)
Balance (in shares) at Sep. 01, 2022		1,226
Balance of total equity at Sep. 01, 2022	49,907	$ 123	10,197	47,274	(7,127)	(560)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(5,833)			(5,833)
Other comprehensive income (loss), net	248					248
Stock issued under equity compensation plans (in shares)		15
Stock issued under equity compensation plans	263	$ 1	262
Stock-based compensation expense	596		596
Repurchase of stock - repurchase program	(425)				(425)
Repurchase of stock - withholdings on employee equity awards (in shares)		(2)
Repurchase of stock - withholdings on employee equity awards	$ (127)	$ 0	(19)	(108)
Dividends and dividend equivalents declared (per share)	$ 0.460
Dividends and dividend equivalents declared	$ (509)			(509)
Balance (in shares) at Aug. 31, 2023	1,239	1,239
Balance of total equity at Aug. 31, 2023	$ 44,120	$ 124	11,036	40,824	(7,552)	(312)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	778			778
Other comprehensive income (loss), net	178					178
Stock issued under equity compensation plans (in shares)		17
Stock issued under equity compensation plans	272	$ 1	271
Stock-based compensation expense	833		833
Repurchase of stock - repurchase program	(300)				(300)
Repurchase of stock - withholdings on employee equity awards (in shares)		(3)
Repurchase of stock - withholdings on employee equity awards	$ (232)	$ 0	(25)	(207)
Dividends and dividend equivalents declared (per share)	$ 0.460
Dividends and dividend equivalents declared	$ (518)			(518)
Balance (in shares) at Aug. 29, 2024	1,253	1,253
Balance of total equity at Aug. 29, 2024	$ 45,131	$ 125	$ 12,115	$ 40,877	$ (7,852)	$ (134)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Cash flows from operating activities
Net income (loss)	$ 778	$ (5,833)	$ 8,687
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation expense and amortization of intangible assets	7,780	7,756	7,116
Stock-based compensation	833	596	514
Provision to write down inventories to net realizable value	0	1,831	0
Goodwill impairment	0	101	0
Change in operating assets and liabilities:
Receivables	(3,581)	2,763	190
Inventories	(488)	(3,555)	(2,179)
Accounts payable and accrued expenses	1,915	(1,302)	334
Other current liabilities	989	(817)	400
Other	281	19	119
Net cash provided by operating activities	8,507	1,559	15,181
Cash flows from investing activities
Expenditures for property, plant, and equipment	(8,386)	(7,676)	(12,067)
Purchases of available-for-sale securities	(1,999)	(723)	(1,770)
Proceeds from maturities and sales of available-for-sale securities	1,794	1,591	1,615
Proceeds from government incentives	315	710	115
Proceeds from sale of Lehi, Utah fab	0	0	888
Other	(33)	(93)	(366)
Net cash provided by (used for) investing activities	(8,309)	(6,191)	(11,585)
Cash flows from financing activities
Repayments of debt	(1,897)	(761)	(2,032)
Payments of dividends to shareholders	(513)	(504)	(461)
Repurchases of common stock - repurchase program	(300)	(425)	(2,432)
Payments on equipment purchase contracts	(149)	(138)	(141)
Proceeds from issuance of debt	999	6,716	2,000
Other	18	95	86
Net cash provided by (used for) financing activities	(1,842)	4,983	(2,980)
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash	40	(34)	(106)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(1,604)	317	510
Cash, cash equivalents, and restricted cash at beginning of period	8,656	8,339	7,829
Cash, cash equivalents, and restricted cash at end of period	7,052	8,656	8,339
Supplemental disclosures
Income taxes paid, net	(338)	(532)	(493)
Interest paid, net of amounts capitalized	(503)	(323)	(154)
Noncash equipment acquisitions on contracts payable	$ 118	$ 165	$ 157

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Aug. 29, 2024
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Basis of Presentation We are an industry leader in innovative memory and storage solutions transforming how the world uses information to enrich life for all . With a relentless focus on our customers, technology leadership, and manufacturing and operational excellence, Micron delivers a rich portfolio of high-performance DRAM, NAND, and NOR memory and storage products through our Micron® and Crucial® brands. Every day, the innovations that our people create fuel the data economy, enabling advances in artificial intelligence (AI) and compute-intensive applications that unleash opportunities — from the data center to the intelligent edge and across the client and mobile user experience. The accompanying consolidated financial statements include the accounts of Micron Technology, Inc. and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America. Intercompany balances and transactions have been eliminated in consolidation. Certain reclassifications have been made to prior period amounts to conform to current period presentation. Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal 2024, 2023, and 2022 each contained 52 weeks. All period references are to our fiscal periods unless otherwise indicated. Derivative and Hedging Instruments We use derivative instruments to manage our exposure to changes in currency exchange rates from (1) our monetary assets and liabilities denominated in currencies other than the U.S. dollar, (2) non-U.S.-dollar-denominated investments in debt instruments, and (3) forecasted cash flows for certain capital expenditures and manufacturing costs. We also use derivative instruments to manage our exposure to changes in commodity prices for manufacturing supplies and to minimize certain exposures to changes in the fair value of fixed-rate debt that result from fluctuations in benchmark interest rates. Derivative instruments are measured at their fair values and recognized as either assets or liabilities. The accounting for changes in the fair value of derivative instruments is based on the intended use of the derivative and the resulting designation. For derivative instruments that are not designated for hedge accounting, gains or losses from changes in fair values are recognized in other non-operating income (expense) and cash flows are classified as investing activities in the statement of cash flows. For derivative instruments designated as cash flow hedges, gains or losses are included as a component of accumulated other comprehensive income and reclassified into earnings in the same line items and in the same periods in which the underlying transactions affect earnings. For derivative instruments designated as fair value hedges, changes in the fair values of the derivative instruments and the offsetting changes in the fair values of the underlying hedged items are both recognized in earnings. For foreign currency and commodity derivative instruments designated as cash flow hedges or fair value hedges, time value is excluded from the assessment of effectiveness and the gains and losses attributable to time value are recognized in earnings through an amortization approach. Cash flows from derivative instruments designated as cash flow hedges or fair value hedges are classified in the same category as the items being hedged. We enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled with each counterparty have been presented in our consolidated balance sheet on a net basis. Financial Instruments Cash equivalents include highly liquid short-term investments with original maturities at the time of purchase of three months or less that are readily convertible to known amounts of cash. Other investments with remaining maturities of less than one year are included in short-term investments. Investments with remaining maturities greater than one year are included in long-term marketable investments. The carrying value of investment securities sold is determined using the specific identification method. Functional Currency The U.S. dollar is the functional currency for us and all of our consolidated subsidiaries. Goodwill We perform an annual impairment assessment for goodwill in our fourth quarter each year. Government Incentives We receive incentives from governmental entities related to capital expenditures, expenses, and other activities. Our government incentives may require that we meet or maintain specified spending levels and other operational metrics and may be subject to reimbursement if such conditions are not met or maintained. Government incentives are recorded in the financial statements in accordance with their purpose: as a reduction of asset costs or a reduction of expenses. Incentives related to the acquisition or construction of fixed assets are recognized as a reduction in the carrying amounts of the related assets and as a reduction to depreciation expense over the useful lives of the assets. Incentives related to specific operating activities are offset against the related expense in the period the expense is incurred. Government incentives received prior to being earned are recognized in current or noncurrent deferred income, whereas government incentives earned prior to being received are recognized in current or noncurrent receivables. Cash received from government incentives related to operating expenses is included as an operating activity in the statement of cash flows, whereas cash received from incentives related to the acquisition of property, plant, and equipment is included as an investing activity. Inventories Inventories are stated at the lower of cost or net realizable value, with cost being determined on a FIFO basis. Cost includes depreciation, labor, material, and overhead costs, including product and process technology costs. Determining net realizable value of finished goods and work in process inventories requires projecting future average selling prices, sales volumes, and costs per part. When net realizable value is below cost, we record a charge to cost of goods sold to write down inventories to their estimated net realizable value in advance of when inventories are actually sold. We review the major characteristics of product type and markets in determining the unit of account for which we perform the lower of cost or net realizable value analysis and categorize all inventories (including DRAM, NAND, and other memory) as a single group. Leases We determine if an arrangement is a lease, or contains a lease, at the inception of the arrangement and evaluate whether the lease is an operating lease or a finance lease at the commencement date. We recognize right-of-use assets and lease liabilities for operating and finance leases with terms greater than 12 months. Right-of-use assets represent our right to use an asset for the lease term, while lease liabilities represent our obligation to make lease payments. We do not separate lease and non-lease components for real-estate and gas plant leases. Sublease income is included within lease expense. Product and Process Technology Costs incurred to (1) acquire product and process technology, (2) patent technology, and (3) keep patents in force, are capitalized and amortized on a straight-line basis over periods ranging up to 12.5 years. We capitalize a portion of costs incurred to patent technology based on historical data of patents issued as a percent of patents we file. Product and process technology costs are amortized over the shorter of (1) the estimated useful life of the technology, (2) the patent term, or (3) the term of the technology agreement. Fully-amortized assets are removed from product and process technology and accumulated amortization. Product Warranty We generally provide a limited warranty that our products are in compliance with applicable specifications existing at the time of delivery. Under our standard terms and conditions of sale, liability for certain failures of product during a stated warranty period is usually limited to repair or replacement of defective items or return of, or a credit with respect to, amounts paid for such items. Under certain circumstances, we provide more extensive limited warranty coverage than that provided under our standard terms and conditions. Our warranty obligations are not material. Property, Plant, and Equipment Property, plant, and equipment is stated at cost and depreciated using the straight-line method over estimated useful lives of generally 10 to 30 years for buildings, 7 years for production equipment, up to 7 years for other equipment, and 3 to 5 years for software. Assets held for sale are carried at the lower of estimated fair value or carrying value and are included in current assets. When property, plant, or equipment is retired or otherwise disposed, the net book value is removed and we recognize any gain or loss in results of operations. We capitalize interest on borrowings during the period of time we carry out the activities necessary to bring assets to the condition of their intended use and location. We utilize a weighted average capitalization rate that is based on our consolidated debt portfolio. Capitalized interest becomes part of the cost of assets. Research and Development Costs related to the conceptual formulation and design of products and processes are charged to R&D expense as incurred. Development of a product is deemed complete when it is qualified through reviews and tests for performance and reliability. Subsequent to product qualification, product costs are included in cost of goods sold. Revenue Recognition Revenue is primarily recognized at a point in time when control of the promised goods is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods. Contracts with our customers are generally short-term in duration at fixed, negotiated prices with payment generally due shortly after delivery. We estimate a liability for returns using the expected value method based on historical returns. In addition, we generally offer price protection to our distributors, which is a form of variable consideration that decreases the transaction price. We use the expected value method, based on historical price adjustments and current pricing trends, to estimate the amount of revenue recognized from sales to distributors. Differences between the estimated and actual amounts are recognized as adjustments to revenue. Stock-based Compensation Stock-based compensation is measured at the grant date, based on the fair value of the award, and recognized as expense under the straight-line attribution method over the requisite service period. We account for forfeitures as they occur. We issue new shares upon the exercise of stock options, conversion of share units, or issuance of shares under our ESPP. Treasury Stock Treasury stock is carried at cost. When we retire our treasury stock, any excess of the repurchase price paid over par value is allocated between additional capital and retained earnings. Use of Estimates The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that we believe to be reasonable under the circumstances. Estimates and judgments may differ under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis. Actual results could differ from estimates.

Recently Issued Accounting Stan

Recently Issued Accounting Standards	12 Months Ended
	Aug. 29, 2024
Accounting Changes and Error Corrections [Abstract]
Recently Issued Accounting Standards	Recently Issued Accounting Standards In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07 (ASC Topic 280), Improvements to Reportable Segment Disclosures . This ASU expands on existing reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. This ASU is effective for our annual reporting for 2025 on a retrospective basis. This standard will impact our disclosures and will not impact our financial statements. In December 2023, the FASB issued ASU 2023-09 (ASC Topic 740), Improvements to Income Tax Disclosures . This ASU requires disaggregated income tax disclosures on the rate reconciliation and income taxes paid. This ASU will be effective for our annual reporting for 2026 on a prospective basis, with retrospective application permitted. This standard will impact our disclosures and will not impact our financial statements.

Variable Interest Entities

Variable Interest Entities	12 Months Ended
	Aug. 29, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	Variable Interest Entities A number of special purpose entities (the "Lease SPEs") were created by a third-party to facilitate equipment lease financing transactions between us and financial institutions that fund the lease financing transactions ("Financing Entities"). Neither we nor the Financing Entities have an equity interest in the Lease SPEs. The Lease SPEs are variable interest entities because their equity is not sufficient to permit them to finance their activities without additional support from the Financing Entities and because the third-party equity holder lacks characteristics of a controlling financial interest. By design, the arrangements with the Lease SPEs are merely financing vehicles and we do not bear any significant risks from variable interests with the Lease SPEs. We have determined that we do not have the power to direct the activities of the Lease SPEs that most significantly impact their economic performance and we do not consolidate the Lease SPEs. As of August 29, 2024, we had approximately $680 million of financial lease liabilities and right-of-use assets under these arrangements.

Cash and Investments

Cash and Investments	12 Months Ended
	Aug. 29, 2024
Investments and Cash [Abstract]
Cash and Investments	Cash and Investments All of our short-term investments and long-term marketable investments were classified as available-for-sale as of the dates noted below. Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows: As of August 29, 2024 As of August 31, 2023 Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash $ 6,654 $ — $ — $ 6,654 $ 5,771 $ — $ — $ 5,771 Level 1 (2) Money market funds 20 — — 20 1,629 — — 1,629 Level 2 (3) Certificates of deposit 316 6 — 322 1,172 25 — 1,197 Corporate bonds — 771 571 1,342 — 737 437 1,174 Asset-backed securities — 46 433 479 — 15 387 402 Commercial paper 16 160 — 176 — 109 — 109 Government securities 35 82 42 159 5 131 20 156 7,041 $ 1,065 $ 1,046 $ 9,152 8,577 $ 1,017 $ 844 $ 10,438 Restricted cash (4) 11 79 Cash, cash equivalents, and restricted cash $ 7,052 $ 8,656 (1) The maturities of long-term marketable investments primarily range from one five years, except for asset-backed securities which are not due at a single maturity date. (2) The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. (3) The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of August 29, 2024 or August 31, 2023. (4) Restricted cash is included in other current assets and other noncurrent assets and primarily relates to certain government incentives received prior to being earned and for which restrictions lapse upon achieving certain performance conditions or which will be returned if performance conditions are not met. Gross realized gains and losses from sales of available-for-sale securities were not significant for any period presented. Non-marketable Equity Investments

Receivables

Receivables	12 Months Ended
	Aug. 29, 2024
Receivables [Abstract]
Receivables	Receivables As of August 29, August 31, Trade receivables $ 5,419 $ 2,048 Government incentives 834 105 Income and other taxes 268 194 Other 94 96 $ 6,615 $ 2,443

Inventories

Inventories	12 Months Ended
	Aug. 29, 2024
Inventory Disclosure [Abstract]
Inventories	Inventories As of August 29, August 31, Finished goods $ 1,308 $ 1,616 Work in process 6,774 6,111 Raw materials and supplies 793 660 $ 8,875 $ 8,387

Property, Plant, and Equipment

Property, Plant, and Equipment	12 Months Ended
	Aug. 29, 2024
Property, Plant and Equipment [Abstract]
Property, Plant, and Equipment	Property, Plant, and Equipment As of August 29, August 31, Land $ 284 $ 283 Buildings 20,141 17,967 Equipment (1) 70,813 65,555 Construction in progress (2) 3,444 2,464 Software 1,365 1,316 96,047 87,585 Accumulated depreciation (56,298) (49,657) $ 39,749 $ 37,928 (1) Includes costs related to equipment not placed into service of $3.10 billion as of August 29, 2024 and $2.91 billion as of August 31, 2023. (2) Primarily includes building-related construction and tool installation. Depreciation expense was $7.70 billion, $7.67 billion, and $7.03 billion for 2024, 2023, and 2022, respectively. Interest capitalized as part of the cost of property, plant, and equipment was $225 million, $208 million, and $77 million for 2024, 2023, and 2022, respectively.

Leases

Leases	12 Months Ended
	Aug. 29, 2024
Leases [Abstract]
[Finance] Leases	Leases We have finance and operating leases through which we obtain the right to use facilities, land, and equipment that support our business operations. Our finance leas es consist primarily of (i) gas and other supply agreements that are deemed to contain embedded leases and (ii) equipment leases. Ou r operating leases consist primarily of offices, laboratories, other facilities, and land. Certain of our operating leases include one or more options to extend the lease term for periods from one year to 10 years for real estate and one year to 99 years for land. Certain supply or service agreements require us to exercise significant judgment to determine whether the agreement contains a lease. Our assessment includes determining whether we or the supplier control the assets used to fulfill the agreements by identifying whether we or the supplier have the right to change the type, quantity, timing, or location of the output of the assets. Our gas supply arrangements generally are deemed to contain a lease because we have the right to substantially all of the output of the assets used to produce the supply and we have the right to change the quantity and timing of the output of those assets. In determining the lease term, we assess whether we are reasonably certain to exercise any options to renew or terminate a lease or to purchase the right-of-use asset. Measuring the present value of the initial lease liability requires judgment to determine the discount rate, which we base on interest rates for borrowings with similar terms and collateral issued by entities with credit ratings similar to ours. The components of lease cost are presented below: For the year ended 2024 2023 2022 Finance lease cost Amortization of right-of-use asset $ 176 $ 105 $ 99 Interest on lease liability 70 24 24 Operating lease cost (1) 140 137 125 $ 386 $ 266 $ 248 (1) Operating lease cost includes short-term and variable lease expenses, which were not material for the periods presented. Supplemental cash flow information related to leases was as follows: For the year ended 2024 2023 2022 Cash flows used for operating activities Finance leases $ 61 $ 24 $ 23 Operating leases 132 139 110 Cash flows used for financing activities – Finance leases 155 109 103 Noncash acquisitions of right-of-use assets Finance leases 905 508 309 Operating leases 54 57 197 Supplemental balance sheet information related to leases was as follows: As of August 29, August 31, Finance lease right-of-use assets (included in property, plant, and equipment) $ 2,038 $ 1,311 Current operating lease liabilities (included in accounts payable and accrued expenses) 71 66 Weighted-average remaining lease term (in years) Finance leases 8 9 Operating leases 10 11 Weighted-average discount rate Finance leases 4.91 % 3.86 % Operating leases 3.42 % 3.21 % As of August 29, 2024, maturities of lease liabilities by fiscal year were as follows: Finance Leases Operating Leases 2025 $ 400 $ 93 2026 380 82 2027 373 87 2028 362 82 2029 279 76 2030 and thereafter 568 398 Less imputed interest (308) (137) $ 2,054 $ 681 The table above excludes obligations for leases that have been executed but have not yet commenced. As of August 29, 2024, excluded obligations consisted of $835 million of finance lease obligations over a weighted-average period of 13 years for gas supply arrangements deemed to contain embedded leases and equipment leases. We will recognize right-of-use assets and associated lease liabilities at the time such assets become available for our use.
[Operating] Leases	Leases We have finance and operating leases through which we obtain the right to use facilities, land, and equipment that support our business operations. Our finance leas es consist primarily of (i) gas and other supply agreements that are deemed to contain embedded leases and (ii) equipment leases. Ou r operating leases consist primarily of offices, laboratories, other facilities, and land. Certain of our operating leases include one or more options to extend the lease term for periods from one year to 10 years for real estate and one year to 99 years for land. Certain supply or service agreements require us to exercise significant judgment to determine whether the agreement contains a lease. Our assessment includes determining whether we or the supplier control the assets used to fulfill the agreements by identifying whether we or the supplier have the right to change the type, quantity, timing, or location of the output of the assets. Our gas supply arrangements generally are deemed to contain a lease because we have the right to substantially all of the output of the assets used to produce the supply and we have the right to change the quantity and timing of the output of those assets. In determining the lease term, we assess whether we are reasonably certain to exercise any options to renew or terminate a lease or to purchase the right-of-use asset. Measuring the present value of the initial lease liability requires judgment to determine the discount rate, which we base on interest rates for borrowings with similar terms and collateral issued by entities with credit ratings similar to ours. The components of lease cost are presented below: For the year ended 2024 2023 2022 Finance lease cost Amortization of right-of-use asset $ 176 $ 105 $ 99 Interest on lease liability 70 24 24 Operating lease cost (1) 140 137 125 $ 386 $ 266 $ 248 (1) Operating lease cost includes short-term and variable lease expenses, which were not material for the periods presented. Supplemental cash flow information related to leases was as follows: For the year ended 2024 2023 2022 Cash flows used for operating activities Finance leases $ 61 $ 24 $ 23 Operating leases 132 139 110 Cash flows used for financing activities – Finance leases 155 109 103 Noncash acquisitions of right-of-use assets Finance leases 905 508 309 Operating leases 54 57 197 Supplemental balance sheet information related to leases was as follows: As of August 29, August 31, Finance lease right-of-use assets (included in property, plant, and equipment) $ 2,038 $ 1,311 Current operating lease liabilities (included in accounts payable and accrued expenses) 71 66 Weighted-average remaining lease term (in years) Finance leases 8 9 Operating leases 10 11 Weighted-average discount rate Finance leases 4.91 % 3.86 % Operating leases 3.42 % 3.21 % As of August 29, 2024, maturities of lease liabilities by fiscal year were as follows: Finance Leases Operating Leases 2025 $ 400 $ 93 2026 380 82 2027 373 87 2028 362 82 2029 279 76 2030 and thereafter 568 398 Less imputed interest (308) (137) $ 2,054 $ 681 The table above excludes obligations for leases that have been executed but have not yet commenced. As of August 29, 2024, excluded obligations consisted of $835 million of finance lease obligations over a weighted-average period of 13 years for gas supply arrangements deemed to contain embedded leases and equipment leases. We will recognize right-of-use assets and associated lease liabilities at the time such assets become available for our use.

Intangible Assets

Intangible Assets	12 Months Ended
	Aug. 29, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets As of August 29, 2024 As of August 31, 2023 Gross Accumulated Net Carrying Amount Gross Accumulated Net Carrying Amount Product and process technology $ 683 $ (278) $ 405 $ 613 $ (209) $ 404 Other 11 — 11 — — — $ 694 $ (278) $ 416 $ 613 $ (209) $ 404 In 2024, 2023, and 2022, we capitalized $84 million, $87 million, and $158 million, respectively, for product and process technology with weighted-average useful lives of 10 years, 9 years, and 9 years, respectively. Amortization expense was $82 million, $86 million, and $85 million for 2024, 2023, and 2022, respectively. Expected amortization expense is $67 million for 2025, $56 million for 2026, $52 million for 2027, $49 million for 2028, and $42 million for 2029.

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	12 Months Ended
	Aug. 29, 2024
Payables and Accruals [Abstract]
Accounts Payable and Accrued Expenses	Accounts Payable and Accrued Expenses As of August 29, August 31, Accounts payable $ 2,726 $ 1,725 Property, plant, and equipment 2,925 1,419 Salaries, wages, and benefits 1,117 367 Income and other taxes 218 67 Other 313 380 $ 7,299 $ 3,958

Debt

Debt	12 Months Ended
	Aug. 29, 2024
Debt Disclosure [Abstract]
Debt	Debt As of August 29, 2024 As of August 31, 2023 Net Carrying Amount Net Carrying Amount Stated Rate Effective Rate Principal Current Long-Term Total Principal Current Long-Term Total 2026 Term Loan A 6.819 % 6.95 % $ 922 $ 49 $ 872 $ 921 $ 971 $ 49 $ 921 $ 970 2027 Term Loan A 6.944 % 7.08 % 1,065 57 1,006 1,063 1,123 57 1,063 1,120 2026 Notes 4.975 % 5.07 % 500 — 499 499 500 — 499 499 2027 Notes (1) 4.185 % 4.27 % 900 — 838 838 900 — 798 798 2028 Notes 5.375 % 5.52 % 600 — 597 597 600 — 596 596 2029 A Notes 5.327 % 5.40 % 700 — 698 698 700 — 697 697 2029 B Notes 6.750 % 6.54 % 1,250 — 1,261 1,261 1,250 — 1,263 1,263 2030 Notes 4.663 % 4.73 % 850 — 847 847 850 — 846 846 2031 Notes 5.300 % 5.41 % 1,000 — 994 994 — — — — 2032 Green Bonds 2.703 % 2.77 % 1,000 — 996 996 1,000 — 995 995 2033 A Notes 5.875 % 5.96 % 750 — 745 745 750 — 745 745 2033 B Notes 5.875 % 6.01 % 900 — 891 891 900 — 890 890 2041 Notes 3.366 % 3.41 % 500 — 497 497 500 — 497 497 2051 Notes 3.477 % 3.52 % 500 — 496 496 500 — 496 496 2024 Term Loan A N/A N/A — — — — 588 — 587 587 2025 Term Loan A N/A N/A — — — — 1,052 — 1,050 1,050 Finance lease obligations N/A 4.91 % 2,054 325 1,729 2,054 1,281 172 1,109 1,281 $ 13,491 $ 431 $ 12,966 $ 13,397 $ 13,465 $ 278 $ 13,052 $ 13,330 (1) In 2021, we entered into fixed-to-floating interest rate swaps on the 2027 Notes with an aggregate $900 million notional amount equal to the principal amount of the 2027 Notes. The resulting variable interest paid is at a rate equal to SOFR As of August 29, 2024, all of our debt, other than finance lease obligations, were unsecured obligations that rank equally in right of payment with all of our other existing and future unsecured indebtedness and were effectively subordinated to all future secured indebtedness, to the extent of the value of the assets securing such indebtedness. All our unsecured debt were obligations of our parent company, Micron, and were structurally subordinated to all liabilities of its subsidiaries, including trade payables. The terms of our indebtedness generally contain cross payment default and cross acceleration provisions. Micron’s guarantees of certain liabilities of its subsidiaries are unsecured obligations ranking equally in right of payment with all of Micron’s other existing and future unsecured indebtedness. Debt Activity The table below presents the effects of debt financing and prepayment activities in 2024: Transaction Date Increase (Decrease) in Principal Increase (Decrease) in Carrying Value Increase (Decrease) in Cash Issuances 2031 Notes January 12, 2024 $ 1,000 $ 993 $ 993 Prepayments 2024 Term Loan A January 12, 2024 (588) (587) (588) 2025 Term Loan A January 12, 2024 (402) (401) (402) 2025 Term Loan A May 29, 2024 (650) (649) (650) $ (640) $ (644) $ (647) In 2023, we issued $6.70 billion of senior unsecured notes and term loan agreements and received cash of $6.69 billion. We prepaid $600 million of principal amount of the 2024 Term Loan A. In 2022, we issued $2.00 billion of senior unsecured notes and received cash of $1.99 billion. We prepaid $1.85 billion of principal amount of notes for $1.93 billion in cash. We recognized losses of $83 million in connection with these prepayments. Senior Unsecured Notes We may redeem our 2026 Notes, 2027 Notes, 2028 Notes, 2029 A Notes, 2029 B Notes, 2030 Notes, 2031 Notes, 2032 Green Bonds, 2033 A Notes, 2033 B Notes, 2041 Notes, and 2051 Notes (the “Senior Unsecured Notes”), in whole or in part, at our option prior to their respective maturity dates at a redemption price equal to the greater of (i) 100% of the principal amount of the Senior Unsecured Notes to be redeemed and (ii) the present value of the remaining scheduled payments of principal and interest, in each case plus accrued interest. We may also redeem any series of our Senior Unsecured Notes, in whole or in part, at a price equal to par between one and six months prior to maturity in accordance with the respective terms of such series. Each series of Senior Unsecured Notes contains covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our restricted subsidiaries (which are generally domestic subsidiaries in which we own at least 80% of the voting stock and which own principal property, as defined in the indenture governing such series) to (1) create or incur certain liens; (2) enter into certain sale and lease-back transactions; and (3) consolidate with or merge with or into, or convey, transfer, or lease all or substantially all of our properties and assets, to another entity. These covenants are subject to a number of limitations and exceptions. Additionally, if a change of control triggering event, as defined in the indentures governing our Senior Unsecured Notes, occurs with respect to a series of Senior Unsecured Notes, we will be required to offer to purchase such Senior Unsecured Notes at 101% of the outstanding aggregate principal amount plus accrued interest up to the purchase date. Multi-Tranche Term Loan Agreement The 2026 Term Loan A and 2027 Term Loan A (the “Multi-Tranche Term Loan Agreement”) require equal quarterly installment payments in an amount equal to 1.25% of the original principal amount. Borrowings under the Multi-Tranche Term Loan Agreement will generally bear interest at adjusted term SOFR plus an applicable interest rate margin ranging from 1.00% to 2.00%, varying by tranche and depending on our corporate credit ratings. Adjusted term SOFR for the Multi-Tranche Term Loan Agreement is the SOFR benchmark plus 0.10%. The Multi-Tranche Term Loan Agreement requires us to maintain, on a consolidated basis, a leverage ratio of total indebtedness to adjusted EBITDA, as defined in the Multi-Tranche Term Loan Agreement and calculated as of the last day of each fiscal quarter, not to exceed 3.25 to 1.00, subject to a temporary four quarter increase in such ratio to 3.75 to 1.00 following certain material acquisitions. The Multi-Tranche Term Loan Agreement contains other covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our restricted subsidiaries to (1) create or incur certain liens and enter into sale and lease-back transactions, (2) create, assume, incur, or guarantee certain additional secured indebtedness and unsecured indebtedness of our restricted subsidiaries, and (3) consolidate with or merge with or into, or convey, transfer, lease, or otherwise dispose of all or substantially all of our assets, to another entity. These covenants are subject to a number of limitations, exceptions, and qualifications. Our obligations under the Multi-Tranche Term Loan Agreement are unsecured. Revolving Credit Facility As of August 29, 2024, no amounts were outstanding under the Revolving Credit Facility and $2.50 billion was available to us. Under the Revolving Credit Facility, borrowings would generally bear interest at a rate equal to adjusted term SOFR plus 1.00% to 1.75%, depending on our corporate credit ratings. Adjusted term SOFR for the Revolving Credit Facility agreement is the SOFR benchmark plus a credit spread adjustment ranging from approximately 0.11% to 0.43% depending on the applicable interest period selected. Any amounts outstanding under the Revolving Credit Facility would mature in May 2026 and amounts borrowed may be prepaid without penalty. The Revolving Credit Facility contains the same leverage ratio and substantially the same other covenants as the Multi-Tranche Term Loan Agreement. Maturities of Notes Payable As of August 29, 2024, maturities of notes payable by fiscal year were as follows: 2025 $ 107 2026 607 2027 1,780 2028 1,493 2029 700 2030 and thereafter 6,750 Unamortized issuance costs, discounts, and premium, net (34) Hedge accounting fair value adjustment (60) $ 11,343

Commitments

Commitments	12 Months Ended
	Aug. 29, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments	Commitments As of August 29, 2024, we had noncancelable commitments with remaining contractual terms in excess of one year of approximately $6.7 billion for purchase obligations, of which approximately $1.7 billion will be due in 2025, $1.7 billion due in 2026, $1.0 billion due in 2027, $800 million due in 2028, $200 million due in 2029, and $1.3 billion due in 2030 and thereafter. Purchase obligations primarily include payments for goods or services with either a fixed or minimum quantity and price, which includes payments for the acquisition of property, plant, and equipment. Payments for leases that have been executed but have not yet commenced are excluded. In 2023, we entered into an 18-year power purchase agreement in Singapore to purchase up to 450 megawatts of power at predominantly variable prices. This contract is expected to supply the majority of our power consumption needs in Singapore with more favorable pricing than our previous supply arrangements.

Contingencies

Contingencies	12 Months Ended
	Aug. 29, 2024
Loss Contingency [Abstract]
Contingencies	Contingencies We are currently a party to legal actions other than those described below arising from the normal course of business, none of which are expected to have a material adverse effect on our business, results of operations, or financial condition. Patent Matters As is typical in the semiconductor and other high-tech industries, from time to time, others have asserted, and may in the future assert, that our products or manufacturing processes infringe upon their intellectual property rights. A description of certain claims is below. On April 28, 2021, Netlist, Inc. (“Netlist”) filed two patent infringement actions against Micron, Micron Semiconductor Products, Inc. (“MSP”), and Micron Technology Texas, LLC (“MTEC”) in the U.S. District Court for the Western District of Texas. The first complaint alleges that one U.S. patent is infringed by certain of our non-volatile dual in-line memory modules. The second complaint alleges that three U.S. patents are infringed by certain of our load-reduced dual in-line memory modules (“LRDIMMs”). Each complaint seeks injunctive relief, damages, attorneys’ fees, and costs. On March 31, 2022, Netlist filed a patent infringement complaint against Micron and Micron Semiconductor Germany, GmbH in Dusseldorf Regional Court alleging that two German patents are infringed by certain of our LRDIMMs. The complaint seeks damages, costs, and injunctive relief. On June 10, 2022, Netlist filed a patent infringement complaint against Micron, MSP, and MTEC in the U.S. District Court for the Eastern District of Texas (“E.D. Tex.”) alleging that six U.S. patents are infringed by certain of our memory modules and HBM products. On August 1, 2022, Netlist filed a second patent infringement complaint against the same defendants in E.D. Tex. alleging that one U.S. patent is infringed by certain of our LRDIMMs. On August 15, 2022, Netlist amended the second complaint to assert that two additional U.S. patents are infringed by certain of our LRDIMMs. The complaints in E.D. Tex. seek injunctive relief, damages, and attorneys’ fees. On May 23, 2024, following a four-day trial regarding the second complaint filed by Netlist in the E.D. Tex., a jury rendered a verdict that Micron’s memory modules infringe two asserted patents — U.S. Patent No. 7,619,912 (“the ‘912 patent”) and U.S. Patent No. 11,093,417 (“the ‘417 patent”) — and found that Micron should pay $425 million for infringement of the ‘912 patent and $20 million for infringement of the ‘417 patent. Micron expects to appeal the verdict. On April 17, 2024, the Patent Trial and Appeal Board (“PTAB”) of the United States Patent and Trademark Office (“USPTO”) issued a final written decision (“FWD”) finding unpatentable the sole asserted claim of the ‘912 patent. Netlist sought review of that ruling by the Director of the USPTO, which was denied on July 10, 2024. On July 30, 2024, the USPTO issued a FWD finding unpatentable all asserted claims of the ‘417 patent. In the case of each of the ‘912 and ‘417 patents, if the United States Court of Appeals for the Federal Circuit affirms the FWD, then the affirmed FWD will preclude any pending actions asserting infringement of such patent (including any infringement verdict that is subject to an ongoing appeal). On August 16, 2022, Sonrai Memory Ltd. filed a patent infringement complaint against Micron in the U.S. District Court for the Western District of Texas. The complaint alleged that two U.S. patents are infringed by certain SSD and NAND flash products. The complaint sought damages, attorneys’ fees, and costs. On September 6, 2024, pursuant to a motion jointly filed by the parties, the court dismissed Sonrai’s complaint. On January 23, 2023, Besang Inc. filed a patent infringement complaint against Micron in the U.S. District Court for the E.D. Tex. The complaint alleges that one U.S. patent is infringed by certain of our 3D NAND and SSD products. The complaint seeks an injunction, damages, attorneys’ fees, and costs. On November 9, 2023, Yangtze Memory Technologies Company, Ltd. (“YMTC”) filed a patent infringement complaint against Micron and one of its subsidiaries in the U.S. District Court for the Northern District of California (“N.D. Cal.”). The complaint alleges that eight U.S. patents are infringed by certain of our 3D NAND products. The complaint seeks an injunction, damages, attorneys’ fees, and costs. On January 22, 2024, Micron Semiconductor (Shanghai) Co., Ltd. (“MSS”) was served with three patent infringement complaints filed by YMTC in Beijing Intellectual Property Court and on February 27, 2024, Micron Technology, Inc. (“MTI”) was served with the same complaints. The complaints assert that MTI and MSS infringed three Chinese patents owned by YMTC by importing, selling, offering for sale, and assisting others to sell certain 3D NAND products and SSDs in China. The complaint seeks an injunction, damages, attorneys’ fees, and costs. On July 12, 2024, YMTC filed a second complaint against the Company and its subsidiary in N.D. Cal. The second complaint alleges that eleven U.S. patents are infringed by certain of our 3D NAND and DDR5 DRAM products. The complaint seeks an injunction, damages, attorneys’ fees, and costs. On September 11, 2024, MSS was served with five patent infringement complaints filed by YMTC in Shanghai Intellectual Property Court. The complaints assert that MTI and MSS infringed five Chinese patents owned by YMTC by importing, selling, offering for sale, and assisting others to sell certain 3D NAND products and SSDs in China. The complaint seeks an injunction, damages, attorneys’ fees, and costs. On June 3, 2024, MimirIP LLC (“MimirIP”) submitted a complaint to the United States International Trade Commission (“ITC”) alleging that certain of Micron’s DRAM and NAND products infringe six patents owned by MimirIP. The complaint requested the ITC to institute an investigation of such alleged infringement pursuant to Section 337 of the Tariff Act of 1930 and to issue a permanent limited exclusion order barring from entry into the United States such allegedly infringing DRAM and NAND devices and electronic devices containing the same produced by several alleged customers of Micron. On August 27, 2024, MimirIP and the Company filed a joint motion to terminate the ITC investigation, which was granted on September 12, 2024. On June 3, 2024, MimirIP filed a complaint against Micron, two of its subsidiaries, and certain alleged customers of Micron in the E.D. Tex. alleging that the same six patents as are asserted in the ITC are infringed by certain of Micron’s DRAM and NAND products. The complaint sought damages, attorneys’ fees, and costs. On August 30, 2024, the court dismissed the complaint pursuant to a notice of voluntary dismissal filed by MimirIP. On June 4, 2024, MimirIP filed a second complaint against Micron, two of its subsidiaries, and certain alleged customers of Micron in the E.D. Tex. alleging that six additional patents are infringed by certain of Micron’s DRAM and NAND products. The complaint sought damages, attorneys’ fees, and costs. On August 30, 2024, the court dismissed the complaint pursuant to a notice of voluntary dismissal filed by MimirIP. The above lawsuits pertain to substantially all of our DRAM, NAND, and other memory and storage products we manufacture, which account for substantially all of our revenue. Antitrust Matters On May 15, 2018, the Chinese State Administration for Market Regulation (“SAMR”) notified Micron that it was investigating potential collusion and other anticompetitive conduct by DRAM suppliers in China. On May 31, 2018, SAMR made unannounced visits to our sales offices in Beijing, Shanghai, and Shenzhen to seek certain information as part of its investigation. We are cooperating with SAMR in its investigation. Other Matters In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify another party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition. Contingency Assessment We ar e unable to predict the outcome of any of the matters noted above and cannot make a reasonable estimate of the potential loss or range of possible losses. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing, as well as the resolution of any other legal matter noted above, could have a material adverse effect on our business, results of operations, or financial condition.

Equity

Equity	12 Months Ended
	Aug. 29, 2024
Equity [Abstract]
Equity	Equity Common Stock Repurchases Our Board of Directors has authorized the discretionary repurchase of up to $10 billion of our outstanding common stock through open-market purchases, block trades, privately-negotiated transactions, derivative transactions, and/or pursuant to Rule 10b5-1 trading plans. The repurchase authorization has no expiration date, does not obligate us to acquire any common stock, and is subject to market conditions and our ongoing determination of the best use of available cash. We repurchased 3.2 million shares of our common stock for $300 million in 2024 and 8.6 million shares for $425 million in 2023. Through August 29, 2024, we had repurchased an aggregate of $7.19 billion under the authorization. Amounts repurchased are included in treasury stock. Dividends In each quarter of 2024, we declared and paid dividends of $0.115 per share. On September 25, 2024, our Board of Directors declared a quarterly dividend of $0.115 per share, payable in cash on October 23, 2024, to shareholders of record as of the close of business on October 7, 2024. Accumulated Other Comprehensive Income (Loss) Changes in accumulated other comprehensive income (loss) by component for the year ended August 29, 2024 were as follows: Gains (Losses) on Derivative Instruments Unrealized Gains (Losses) on Investments Pension Liability Adjustments Cumulative Foreign Currency Translation Adjustment Total As of August 31, 2023 $ (304) $ (41) $ 36 $ (3) $ (312) Other comprehensive income (loss) before reclassifications 34 33 7 — 74 Amount reclassified out of accumulated other comprehensive income (loss) 172 — (3) — 169 Tax effects (64) — (1) — (65) Other comprehensive income (loss) 142 33 3 — 178 As of August 29, 2024 $ (162) $ (8) $ 39 $ (3) $ (134)

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Aug. 29, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The estimated fair values and carrying values of our outstanding debt instruments were as follows: As of August 29, 2024 As of August 31, 2023 Fair Carrying Fair Carrying Notes $ 11,316 $ 11,343 $ 11,549 $ 12,049 The fair values of our debt instruments were estimated based on Level 2 inputs, including the trading price of our notes when available, discounted cash flows, and interest rates based on similar debt issued by parties with credit ratings similar to ours.

Derivative Instruments

Derivative Instruments	12 Months Ended
	Aug. 29, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments Notional or Contractual Amount Fair Value (1) of Assets (2) Liabilities (3) As of August 29, 2024 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 3,724 $ 57 $ (71) Cash flow commodity hedges 471 20 (7) Fair value currency hedges 2,511 — (41) Fair value interest rate hedges 900 — (60) Derivative instruments without hedge accounting designation Non-designated currency hedges 2,393 18 (3) $ 95 $ (182) As of August 31, 2023 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 3,873 $ 16 $ (180) Cash flow commodity hedges 331 45 — Fair value interest rate hedges 900 — (100) Derivative instruments without hedge accounting designation Non-designated currency hedges 1,839 2 (17) $ 63 $ (297) (1) Forward and swap contracts are measured at fair value based on market-based observable inputs including market spot and forward rates, interest rates, and credit-risk spreads (Level 2). (2) Included in receivables and other noncurrent assets. (3) Included in accounts payable and accrued expenses and other noncurrent liabilities. Derivative Instruments with Hedge Accounting Designation Cash Flow Hedges : We utilize forward and swap contracts that generally mature within two years designated as cash flow hedges to minimize our exposure to changes in currency exchange rates or commodity prices for certain capital expenditures and manufacturing costs. The effects of cash flow hedging activities were as follows: For the year ended 2024 2023 2022 Gain (loss) from cash flow hedges in accumulated other comprehensive income (loss) $ 33 $ 30 $ (735) Gain (loss) excluded from effectiveness testing in cost of goods sold (135) (101) (32) Gain (loss) reclassified from accumulated other comprehensive income (loss) to earnings, primarily to cost of goods sold (172) (261) (53) As of August 29, 2024, we expect to reclassify $89 million of pre-tax losses related to cash flow hedges from accumulated other comprehensive income (loss) into earnings in the next 12 months. Fair Value Hedges : We utilize currency forward contracts that generally mature within one year designated as fair value hedges to minimize our exposure to changes in currency exchange rates for non-U.S.-dollar-denominated cash and investments in debt securities. The fair value of our hedged cash and investments in debt securities was $2.58 billion as of August 29, 2024. The changes in the fair values of derivatives designated as fair value hedges and the offsetting changes in the underlying fair values of the hedged items are both recognized in earnings. The effects of fair value currency hedges on our consolidated statements of operations, recognized in other non-operating income (expense), net, were not significant for the periods presented. We also utilize fixed-to-floating interest rate swaps designated as fair value hedges to minimize certain exposures to changes in the fair value of fixed-rate debt that result from fluctuations in benchmark interest rates. We recognized interest expense of $96 million for changes in the fair value of our interest rate swaps in 2022 and the impact to interest expense was not significant for 2024 or 2023. We also recognized offsetting reductions in interest expense of the same amounts related to the changes in the fair value of the hedged portion of the underlying debt for these periods. Derivative Instruments without Hedge Accounting Designation Currency Derivatives : We generally utilize a rolling hedge strategy with currency forward contracts that mature within three months to hedge our exposures of monetary assets and liabilities from changes in currency exchange rates. At the end of each reporting period, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured into U.S. dollars and the associated outstanding forward contracts are marked to market. Realized and unrealized gains and losses on derivative instruments without hedge accounting designation as well as the changes in the underlying monetary assets and liabilities from changes in currency exchange rates are included in other non-operating income (expense), net. The amounts recognized for derivative instruments without hedge accounting designation were not significant for the periods presented. We do not use derivative instruments for speculative purposes. Derivative Counterparty Credit Risk and Master Netting Arrangements Our derivative instruments expose us to credit risk to the extent counterparties may be unable to meet the terms of the contracts. Our maximum exposure to loss due to credit risk if counterparties fail completely to perform according to the terms of the contracts would generally equal the fair value of assets for these contracts as listed in the tables above. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading risk across multiple financial institutions. As of August 29, 2024 and August 31, 2023, amounts netted under our master netting arrangements were not significant.

Equity Compensation Plans

Equity Compensation Plans	12 Months Ended
	Aug. 29, 2024
Share-Based Payment Arrangement [Abstract]
Equity Plans	Equity Compensation Plans As of August 29, 2024, 69 million shares of our common stock were available for future awards under our equity compensation plans, including 11 million shares approved for issuance under our employee stock purchase plan (“ESPP”). Restricted Stock and Restricted Stock Units (“Restricted Stock Awards”) As of August 29, 2024, there were 28 million shares of Restricted Stock Awards outstanding, 24 million of which are only subject to service-based vesting conditions. Service-based Restricted Stock Awards granted through October 2021 generally vest in one-fourth or one-third increments during each year of employment after the grant date. Service-based Restricted Stock Awards granted after October 2021 generally vest on 25% or 33% of the units granted after the first year and on 6.25% or 8.33% each quarter thereafter over the remaining three or two years of employment. Restricted Stock Awards with performance or market-based vesting conditions vest over a 3-year period as conditions are met. At the end of the performance period, the number of actual shares to be awarded will vary between 0% and 200% of target amounts, depending upon the achievement level. In 2022, our Board of Directors approved dividend equivalent rights for unvested restricted stock units awarded on or after October 13, 2021. Restricted Stock Awards activity for 2024 is summarized as follows: Number of Shares Weighted-Average Grant Date Fair Value Per Share Outstanding as of August 31, 2023 29 $ 59.11 Granted 13 72.72 Vested (12) 57.92 Forfeited (2) 60.42 Outstanding as of August 29, 2024 28 65.82 For the year ended 2024 2023 2022 Restricted stock award shares granted 13 17 13 Weighted-average grant-date fair value per share $ 72.72 $ 55.99 $ 70.81 Aggregate vesting-date fair value of shares vested $ 1,008 $ 514 $ 498 Employee Stock Purchase Plan (“ESPP”) Our ESPP is offered to substantially all employees and permitted eligible employees to purchase shares of our common stock through payroll deductions of up to 15% of their eligible compensation, subject to certain limitations. The purchase price of the shares under the ESPP equals 85% of the lower of the fair market value of our common stock on either the first or last day of each six Black-Scholes For the year ended 2024 2023 2022 Weighted-average grant-date fair value per share $ 26.82 $ 17.06 $ 18.87 Average expected life in years 0.5 0.5 0.5 Weighted-average expected volatility (based on implied volatility) 41 % 37 % 43 % Weighted-average risk-free interest rate 5.2 % 5.1 % 2.0 % Expected dividend yield 0.5 % 0.7 % 0.6 % Under the ESPP, employees purchased 4 million, 5 million, and 4 million shares of common stock in 2024, 2023, and 2022, respectively, at a per share weighted average price of $65.72, $51.93, and $58.52, respectively. Stock Options We last granted stock options in September 2018 and as of August 29, 2024, our outstanding stock options were not material. Stock options of 1.3 million shares were exercised in 2024. The total intrinsic value for options exercised was $92 million, $30 million, and $54 million in 2024, 2023, and 2022, respectively. Stock-based Compensation Expense For the year ended 2024 2023 2022 Stock-based compensation expense by caption Cost of goods sold $ 312 $ 201 $ 193 Research and development 296 226 175 Selling, general, and administrative 213 137 133 Restructure — (7) (5) $ 821 $ 557 $ 496 Stock-based compensation expense by type of award Restricted stock awards $ 749 $ 488 $ 429 ESPP 72 69 66 Stock options — — 1 $ 821 $ 557 $ 496 Income tax benefits related to the tax deductions for share-based awards are recognized only upon the settlement of the related share-based awards. Income tax benefits for share-based awards were $140 million, $68 million, and $77 million for 2024, 2023, and 2022, respectively. Stock-based compensation expense of $99 million and $88 million was capitalized and remained in inventory as of August 29, 2024 and August 31, 2023, respectively. As of August 29, 2024, $1.44 billion of total unrecognized compensation costs for unvested awards, before the effect of any future forfeitures, was expected to be recognized through the fourth quarter of 2028, resulting in a weighted-average period of 1.2 years.

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
	Aug. 29, 2024
Retirement Benefits [Abstract]
Employee Benefit Plans	Employee Benefit Plans We have employee retirement plans at our U.S. and international sites. Details of significant plans are as follows: Employee Savings Plan for U.S. Employees We have a 401(k) retirement plan under which U.S. employees may contribute up to 75% of their eligible pay, subject to Internal Revenue Service annual contribution limits, to various savings alternatives, none of which include direct investment in our stock. We match in cash eligible contributions from employees up to 5% of the employee’s annual eligible earnings. Contribution expense for the 401(k) plan was $66 million, $59 million, and $66 million in 2024, 2023, and 2022, respectively. Retirement Plans We have pension plans available to employees at various foreign sites. As of August 29, 2024, the projected benefit obligations of our plans were $191 million and plan assets were $261 million. As of August 31, 2023, the projected benefit obligations of our plans were $175 million and plan assets were $232 million. Pension expense was not material for 2024, 2023, or 2022.

Government Incentives

Government Incentives	12 Months Ended
	Aug. 29, 2024
Government Assistance [Abstract]
Government Incentives	Government Incentives We receive incentives from governmental entities primarily in India, Japan, Singapore, Taiwan, and the United States principally in the form of cash grants and tax credits. These incentives primarily relate to capital expenditures, have initial terms ranging from one year to 15 years, and may be subject to reimbursement if certain conditions are not met or maintained. The conditions attached to these incentives require us to incur expenditures related to the construction of new manufacturing facilities, the purchase and installation of specialized tools and equipment, R&D expenditures, and/or maintain certain levels of fixed asset investment or employee headcount during the incentive terms. The line items on the balance sheet affected by government incentives were as follows: As of August 29, Receivables $ 834 Other noncurrent assets 188 Noncurrent unearned government incentives 550 Beginning in 2023, we receive a 25% investment tax credit on qualified investments in U.S. semiconductor manufacturing under the CHIPS Act. As qualified investments are made, we recognize investment tax credits in receivables or other noncurrent assets. We have signed a non-binding preliminary memorandum of terms with the U.S. Department of Commerce for up to $6.1 billion in direct funding under the CHIPS Act for our planned fab in Boise, Idaho and the first two planned fabs in Clay, New York. We are also eligible for federal loans up to $7.5 billion. We have also signed a non-binding term sheet with the state of New York that provides up to $5.5 billion in funding for the planned four-fab facility over the next 20-plus years through a combination of tax credits for qualified capital investments and incentives for eligible new job wages. In addition to the receivables and other noncurrent assets in the table above, as of August 29, 2024, we had aggregate commitments from various governmental entities of up to $3.4 billion to be received through 2033, subject to achievement of certain performance conditions. The commitment amount includes $1.8 billion (150 billion Indian rupees) for the construction of a new assembly and test facility in Gujarat, India. We will receive incentives representing 50% of the total project cost from the Indian central government and 20% of the total project cost from the state of Gujarat. The commitment amount also includes up to $1.3 billion (188 billion Japanese yen) from the Japanese Ministry of Economy, Trade and Industry to support the production of DRAM using EUV lithography in Hiroshima, Japan. Government incentives related to capital expenditures have reduced property, plant and equipment In 2024, operating income (loss) benefited by $588 million ( approximately 85% in COGS and 15% in R&D

Revenue and Customer Contract L

Revenue and Customer Contract Liabilities	12 Months Ended
	Aug. 29, 2024
Revenue from Contract with Customer [Abstract]
Revenue and Customer Contract Liabilities	Revenue and Customer Contract Liabilities Revenue by Technology For the year ended 2024 2023 2022 DRAM $ 17,603 $ 10,978 $ 22,386 NAND 7,227 4,206 7,811 Other (primarily NOR) 281 356 561 $ 25,111 $ 15,540 $ 30,758 See “Segment and Other Information” for disclosure of disaggregated revenue by market segment. Revenue is primarily recognized at a point in time when control of the promised goods is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods. Substantially all contracts with our customers are short-term in duration at fixed, negotiated prices with payment generally due shortly after delivery. From time to time, we have contracts with initial terms that include performance obligations that extend beyond one year. As of August 29, 2024, our future performance obligations beyond one year were $141 million, which included customer prepayments and other contract liabilities. Customer prepayments made to secure product supply in future periods and other contract liabilities were $907 million as of August 29, 2024, of which $766 million was reported in other current liabilities and the remainder in other noncurrent liabilities. As of August 29, 2024 and August 31, 2023, other current liabilities included $718 million and $453 million, respectively, for estimates of consideration payable to customers including estimates for pricing adjustments and returns. In 2023, we received an aggregate of $228 million from settlements of insurance claims involving a power disruption in 2022 and an operational disruption in 2017, of which $186 million was for business interruption and recognized in revenue.

Restructure and Asset Impairmen

Restructure and Asset Impairments	12 Months Ended
	Aug. 29, 2024
Restructuring and Related Activities [Abstract]
Restructure and Asset Impairments	Restructure and Asset Impairments For the year ended 2024 2023 2022 Employee severance $ 1 $ 163 $ — Asset impairments and other asset-related costs — 14 63 Other — (6) (15) $ 1 $ 171 $ 48 In 2023, we initiated a restructure plan in response to challenging industry conditions (the “2023 Restructure Plan”). Under the 2023 Restructure Plan, we reduced our headcount by approximately 15% by the end of calendar 2023, through a combination of voluntary attrition and personnel reductions. The plan was substantially completed in 2023. Restructure and asset impairments for 2022 primarily related to the sale of our Lehi, Utah facility to Texas Instruments Incorporated.

Other Operating (Income) Expens

Other Operating (Income) Expense, Net	12 Months Ended
	Aug. 29, 2024
Other Income and Expenses [Abstract]
Other Operating (Income) Expense, Net	Other Operating (Income) Expense, Net For the year ended 2024 2023 2022 Patent cross-license agreement gain $ (200) $ — $ — (Gain) loss on disposition of property, plant, and equipment (59) (54) (41) Goodwill impairment — 101 — Litigation settlement — 68 — Other 8 9 7 $ (251) $ 124 $ (34) We performed a qualitative assessment for goodwill impairment in 2024 and did not identify any impairment indicators for our reporting units. Due to 2023 global and macroeconomic challenges, as well as lower expected demand resulting from customer actions to reduce elevated inventory levels, we performed a 2023 quantitative assessment for goodwill impairment for each of our reporting units. We evaluated the fair value of our reporting units based on an income approach, using a discounted cash flow methodology. We recognized a $101 million charge in 2023, included in other operating income (loss) to impair all of the goodwill assigned to our SBU reporting unit based on our best estimates of projected future cash flows at that time. The 2023 quantitative assessment for all of our other reporting units yielded fair values that substantially exceeded their carrying values.

Income Taxes

Income Taxes	12 Months Ended
	Aug. 29, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our income tax (provision) benefit consisted of the following: For the year ended 2024 2023 2022 Income (loss) before income taxes and equity in net income (loss) of equity method investees U.S. $ 544 $ 235 $ 112 Foreign 696 (5,893) 9,459 $ 1,240 $ (5,658) $ 9,571 Income tax (provision) benefit Current U.S. federal $ (82) $ (5) $ (65) State (1) (1) (1) Foreign (333) (178) (528) (416) (184) (594) Deferred U.S. federal 18 (84) (166) State — — (225) Foreign (53) 91 97 (35) 7 (294) Income tax (provision) benefit $ (451) $ (177) $ (888) The table below reconciles our tax (provision) benefit based on the U.S. federal statutory rate to our effective rate: For the year ended 2024 2023 2022 U.S. federal income tax (provision) benefit at statutory rate $ (260) 21.0 % $ 1,188 21.0 % $ (2,010) 21.0 % U.S. tax on foreign operations (7) 0.6 6 0.1 (322) 3.4 Change in valuation allowance (59) 4.8 (50) (0.9) (241) 2.5 Change in unrecognized tax benefits (41) 3.3 (30) (0.5) (67) 0.7 Foreign tax rate differential (214) 17.2 (1,285) (22.8) 1,601 (16.7) Research and development tax credits 76 (6.1) 43 0.8 66 (0.7) State taxes, net of federal benefit 12 (1.0) 37 0.7 — — Other 42 (3.4) (86) (1.5) 85 (0.9) Income tax (provision) benefit $ (451) 36.4 % $ (177) (3.1) % $ (888) 9.3 % We operate in a number of jurisdictions outside the United States, including Singapore, where we have tax incentive arrangements. These incentives expire, in whole or in part, at various dates through 2034 and are conditional, in part, upon meeting certain business operations and employment thresholds. As a result of low level of profitability and geographic mix of income, the benefit from tax incentive arrangements was not material for 2024 or 2023. These arrangements reduced our tax provision by $1.12 billion ($1.00 per diluted share) for 2022. As of August 29, 2024, certain non-U.S. subsidiaries had cumulative undistributed earnings of $4.12 billion that were deemed to be indefinitely reinvested. A provision has not been recognized to the extent that distributions from such subsidiaries are subject to additional foreign withholding or state income tax. Determination of the amount of unrecognized deferred tax liabilities related to investments in these foreign subsidiaries is not practicable. Deferred income taxes reflect the net tax effects of temporary differences between the bases of assets and liabilities for financial reporting and income tax purposes as well as carryforwards. Deferred tax assets and liabilities consist of the following: As of August 29, August 31, Deferred tax assets Net operating loss and tax credit carryforwards $ 1,050 $ 1,112 Accrued salaries, wages, and benefits 182 39 Operating lease liabilities 175 135 Inventories 4 52 Other 59 75 Gross deferred tax assets 1,470 1,413 Less valuation allowance (593) (528) Deferred tax assets, net of valuation allowance 877 885 Deferred tax liabilities Right-of-use assets (152) (115) Property, plant, and equipment (194) (31) Other (70) (100) Deferred tax liabilities (416) (246) Net deferred tax assets $ 461 $ 639 Reported as Deferred tax assets $ 520 $ 756 Deferred tax liabilities (included in other noncurrent liabilities) (59) (117) Net deferred tax assets $ 461 $ 639 We assess positive and negative evidence for each jurisdiction to determine whether it is more likely than not that existing deferred tax assets will be realized. As of August 29, 2024, and August 31, 2023, we had a valuation allowance of $593 million and $528 million, respectively, against our net deferred tax assets, primarily related to carryforwards in U.S. states and Malaysia. Changes in 2024 in the valuation allowance were due to adjustments based on management's assessment of the realizability of tax credits, allowances and net operating losses based on a level that is more likely than not to be realized. As of August 29, 2024, our net operating loss carryforward amounts and expiration periods, as reported to tax authorities, were as follows: Year of Expiration Malaysia Singapore State Japan Other Total 2025 - 2029 $ — $ — $ 47 $ 144 $ 3 $ 194 2030 - 2034 — — 298 325 126 749 2035 - 2039 — — 285 — — 285 2040 - 2044 — — 94 — — 94 Indefinite 1,224 765 — — — 1,989 $ 1,224 $ 765 $ 724 $ 469 $ 129 $ 3,311 As of August 29, 2024, our tax credit carryforward amounts and expiration periods, as reported to tax authorities, were as follows: Year of Tax Credit Expiration U.S. Federal State Other Total 2025 - 2029 $ — $ 61 $ — $ 61 2030 - 2034 47 134 2 183 2035 - 2039 48 140 44 232 2040 - 2045 315 6 — 321 Indefinite — 145 — 145 $ 410 $ 486 $ 46 $ 942 Below is a reconciliation of the beginning and ending amount of our unrecognized tax benefits: For the year ended 2024 2023 2022 Beginning unrecognized tax benefits $ 744 $ 731 $ 660 Increases related to tax positions from prior years 2 2 14 Increases related to prior year tax positions taken in current year 20 27 — Increases related to tax positions taken in current year 54 17 80 Decreases related to tax positions from prior years (89) (33) (23) Decreases related to settlement with tax authorities (15) — — Ending unrecognized tax benefits $ 716 $ 744 $ 731 As of August 29, 2024, gross unrecognized tax benefits were $716 million, which would have an impact of approximately $633 million on our effective tax rate in the future, if recognized. Amounts accrued for interest and penalties related to uncertain tax positions were not significant for any period presented. The resolution of tax audits or expiration of statute of limitations could also reduce our unrecognized tax benefits. Although the timing of final resolution is uncertain, the estimated potential reduction in our unrecognized tax benefits in the next 12 months would not be significant. We and our subsidiaries file income tax returns with the U.S. federal government, various U.S. states, and various foreign jurisdictions throughout the world. We regularly engage in discussions and negotiations with tax authorities regarding tax matters, including transfer pricing, and we continue to defend any and all such claims presented. Our U.S. federal and state tax returns remain open to examination for 2018 through 2024. We are currently under audit by the Internal Revenue Service for our 2018 and 2019 tax years. In addition, tax returns that remain open to examination in Singapore, Taiwan and Japan range from the years 2016 to 2024. We believe that adequate amounts of taxes and related interest and penalties have been provided, and any adjustments as a result of examinations are not expected to materially adversely affect our business, results of operations, or financial condition.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Aug. 29, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share For the year ended 2024 2023 2022 Net income (loss) – Basic and Diluted $ 778 $ (5,833) $ 8,687 Weighted-average common shares outstanding – Basic 1,105 1,093 1,112 Dilutive effect of equity compensation plans 13 — 10 Weighted-average common shares outstanding – Diluted 1,118 1,093 1,122 Earnings (loss) per share Basic $ 0.70 $ (5.34) $ 7.81 Diluted 0.70 (5.34) 7.75 Antidilutive potential common shares excluded from the computation of diluted earnings per share, that could dilute basic earnings per share in the future, were as follows at the end of the periods shown: For the year ended 2024 2023 2022 Equity compensation plans 3 33 5

Segment and Other Information

Segment and Other Information	12 Months Ended
	Aug. 29, 2024
Segment Reporting [Abstract]
Segment and Other Information	Segment and Other Information Segment information reported herein is consistent with how it is reviewed and evaluated by our chief operating decision maker. We have the following four business units, which are our reportable segments: Compute and Networking Business Unit (“CNBU”) : Includes memory products and solutions sold into the data center, PC, graphics, and networking markets. Mobile Business Unit (“MBU”) : Includes memory and storage products sold into the smartphone and other mobile-device markets. Embedded Business Unit (“EBU”) : Includes memory and storage products and solutions sold into the intelligent edge through the automotive, industrial, and consumer embedded markets. Storage Business Unit (“SBU”) : Includes SSDs and component-level storage solutions sold into the data center, PC, and consumer markets. Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating income and expenses are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments. As of August 29, 2024 and August 31, 2023, CNBU, MBU, and EBU had goodwill of $855 million, $198 million, and $97 million, respectively. For the year ended 2024 2023 2022 Revenue CNBU $ 9,513 $ 5,710 $ 13,693 MBU 6,354 3,630 7,260 EBU 4,614 3,637 5,235 SBU 4,592 2,553 4,553 All Other 38 10 17 Total revenue $ 25,111 $ 15,540 $ 30,758 Operating income (loss) CNBU $ 980 $ (585) $ 5,844 MBU 114 (1,750) 2,160 EBU 199 382 1,752 SBU (362) (1,887) 513 All Other 17 8 12 948 (3,832) 10,281 Unallocated Lower costs from sale of inventory written down in prior periods 987 844 — Patent cross-license agreement 200 — — Stock-based compensation (821) (564) (501) Restructure and asset impairment (1) (171) (48) Provision to write down inventories to net realizable value — (1,831) — Goodwill impairment — (101) — Litigation settlement — (68) — Other (9) (22) (30) 356 (1,913) (579) Total operating income (loss) $ 1,304 $ (5,745) $ 9,702 Depreciation and amortization expense included in operating income (loss) was as follows: For the year ended 2024 2023 2022 CNBU $ 2,760 $ 2,512 $ 2,766 MBU 2,002 2,149 1,725 EBU 1,491 1,324 1,280 SBU 1,501 1,751 1,323 All Other 8 1 2 Unallocated 18 19 20 $ 7,780 $ 7,756 $ 7,116

Certain Concentrations

Certain Concentrations	12 Months Ended
	Aug. 29, 2024
Risks and Uncertainties [Abstract]
Certain Concentrations	Certain Concentrations Revenue by market segment as a percent of total revenue, rounded to the nearest 5%, is presented in the table below: For the year ended 2024 2023 2022 Data center and networking 35 % 25 % 35 % Mobile 25 % 25 % 25 % PC, graphics, and other 25 % 30 % 25 % Intelligent edge – automotive, industrial, and consumer embedded 20 % 25 % 15 % Percentages of total revenue may not total 100% due to rounding. Revenue from one customer was 10% (primarily included in MBU, EBU, and CNBU segments) of total revenue for 2024. No customer accounted for 10% or more of total revenue in 2023. Revenue from one customer was 12% (primarily included in CNBU and SBU segments) and another customer was 11% (primarily included in MBU, CNBU, and EBU segments) of total revenue in 2022. We generally have multiple sources of supply for our raw materials and production equipment; however, only a limited number of suppliers are capable of delivering certain raw materials and production equipment that meet our standards and, in some cases, materials or production equipment are provided by a single supplier. Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, money market accounts, certificates of deposit, fixed-rate debt securities, trade receivables, share repurchase, and derivative contracts. We invest through high-credit-quality financial institutions and, by policy, generally limit the concentration of credit exposure by restricting investments with any single obligor and monitor credit risk of bank counterparties on an ongoing basis. A concentration of credit risk may exist with respect to receivables of certain customers. We perform ongoing credit evaluations of customers worldwide and generally do not require collateral from our customers. Historically, we have not experienced material losses on receivables. A concentration of risk may also exist with respect to our derivative hedging programs as the number of counterparties to our hedges is limited and the notional amounts are relatively large. We seek to mitigate such risk by limiting our counterparties to major financial institutions and through entering into master netting arrangements.

Geographic Information

Geographic Information	12 Months Ended
	Aug. 29, 2024
Segment Reporting [Abstract]
Geographic Information	Geographic Information Revenue based on the geographic location of our customers’ headquarters was as follows: For the year ended 2024 2023 2022 United States $ 13,168 $ 7,805 $ 16,026 Taiwan 4,708 2,697 6,185 Mainland China (excluding Hong Kong) 3,045 2,181 3,311 Other Asia Pacific 1,330 752 1,223 Hong Kong 1,071 340 1,665 Japan 840 987 1,696 Europe 818 682 505 Other 131 96 147 $ 25,111 $ 15,540 $ 30,758 Long-lived assets by geographic area consisted of property, plant, and equipment and operating lease right-of-use assets and were as follows: As of August 29, August 31, Taiwan $ 14,156 $ 12,926 Singapore 10,588 11,283 Japan 7,085 7,323 United States 6,508 5,196 Malaysia 1,153 1,124 China 486 395 India 338 277 Other 80 70 $ 40,394 $ 38,594

Schedule II Valuation and Quali

Schedule II Valuation and Qualifying Accounts	12 Months Ended
	Aug. 29, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule II Valuation and Qualifying Accounts	SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS (In millions) Balance at Charged Currency Balance at Deferred Tax Asset Valuation Allowance Year ended August 29, 2024 $ 528 $ 57 $ 8 $ 593 Year ended August 31, 2023 471 58 (1) 528 Year ended September 1, 2022 233 241 (3) 471

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Pay vs Performance Disclosure
Net income (loss)	$ 778	$ (5,833)	$ 8,687

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	12 Months Ended
	Aug. 29, 2024 shares	Aug. 29, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
MichaelRay [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On July 19, 2024, Michael Ray, our Senior Vice President, Chief Legal Officer and Corporate Secretary, adopted a Rule 10b5-1 trading arrangement providing for the sale of an aggregate of up to 24,379 shares of our common stock acquired upon the vesting of restricted stock units held by Mr. Ray. The actual number of shares sold under the trading arrangement will be net of shares withheld for taxes upon vesting and settlement of the restricted stock units subject to the trading plan. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The first date that sales of any shares are permitted to be sold under the trading arrangement is January 27, 2025, and subsequent sales under the trading arrangement may occur on a regular basis for the duration of the trading arrangement until July 11, 2025, or earlier if all transactions under the trading arrangement are completed.
Name	Michael Ray
Title	Senior Vice President, Chief Legal Officer and Corporate Secretary
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	July 19, 2024
Expiration Date	July 11, 2025
Aggregate Available	24,379	24,379
SanjayMehrotra [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On August 8, 2024, the Mehrotra Family Trust, a trust for which Sanjay Mehrotra, our President, Chief Executive Officer and Director, serves as trustee, adopted a Rule 10b5-1 trading arrangement providing for the sale of an aggregate of up to 200,000 shares of our common stock acquired by Mr. Mehrotra upon the vesting of certain equity awards held by Mr. Mehrotra. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The first date that sales of any shares are permitted to be sold under the trading arrangement is November 7, 2024, and subsequent sales under the trading arrangement may occur on a regular basis for the duration of the trading arrangement until November 7, 2026, or earlier if all transactions under the trading arrangement are completed. Mr. Mehrotra’s Rule 10b5-1 trading plan, dated as of May 15, 2023, expired by its terms prior to August 8, 2024.
Name	Sanjay Mehrotra
Title	President, Chief Executive Officer and Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 8, 2024
Expiration Date	November 7, 2026
Aggregate Available	200,000	200,000

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
	Aug. 29, 2024
Accounting Policies [Abstract]
Basis of Presentation	The accompanying consolidated financial statements include the accounts of Micron Technology, Inc. and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America.
Intercompany Eliminations	Intercompany balances and transactions have been eliminated in consolidation.
Reclassifications	Certain reclassifications have been made to prior period amounts to conform to current period presentation.
Fiscal Period	Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal 2024, 2023, and 2022 each contained 52 weeks. All period references are to our fiscal periods unless otherwise indicated.
Derivative and Hedging Instruments	Derivative and Hedging Instruments We use derivative instruments to manage our exposure to changes in currency exchange rates from (1) our monetary assets and liabilities denominated in currencies other than the U.S. dollar, (2) non-U.S.-dollar-denominated investments in debt instruments, and (3) forecasted cash flows for certain capital expenditures and manufacturing costs. We also use derivative instruments to manage our exposure to changes in commodity prices for manufacturing supplies and to minimize certain exposures to changes in the fair value of fixed-rate debt that result from fluctuations in benchmark interest rates. Derivative instruments are measured at their fair values and recognized as either assets or liabilities. The accounting for changes in the fair value of derivative instruments is based on the intended use of the derivative and the resulting designation. For derivative instruments that are not designated for hedge accounting, gains or losses from changes in fair values are recognized in other non-operating income (expense) and cash flows are classified as investing activities in the statement of cash flows. For derivative instruments designated as cash flow hedges, gains or losses are included as a component of accumulated other comprehensive income and reclassified into earnings in the same line items and in the same periods in which the underlying transactions affect earnings. For derivative instruments designated as fair value hedges, changes in the fair values of the derivative instruments and the offsetting changes in the fair values of the underlying hedged items are both recognized in earnings. For foreign currency and commodity derivative instruments designated as cash flow hedges or fair value hedges, time value is excluded from the assessment of effectiveness and the gains and losses attributable to time value are recognized in earnings through an amortization approach. Cash flows from derivative instruments designated as cash flow hedges or fair value hedges are classified in the same category as the items being hedged. We enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled with each counterparty have been presented in our consolidated balance sheet on a net basis.
Financial Instruments, Cash Equivalents	Financial Instruments
Financial Instruments, Investments	Financial Instruments Cash equivalents include highly liquid short-term investments with original maturities at the time of purchase of three months or less that are readily convertible to known amounts of cash. Other investments with remaining maturities of less than one year are included in short-term investments. Investments with remaining maturities greater than one year are included in long-term marketable investments. The carrying value of investment securities sold is determined using the specific identification method.
Functional Currency	Functional Currency The U.S. dollar is the functional currency for us and all of our consolidated subsidiaries.
Goodwill	Goodwill We perform an annual impairment assessment for goodwill in our fourth quarter each year.
Government Incentives	Government Incentives We receive incentives from governmental entities related to capital expenditures, expenses, and other activities. Our government incentives may require that we meet or maintain specified spending levels and other operational metrics and may be subject to reimbursement if such conditions are not met or maintained. Government incentives are recorded in the financial statements in accordance with their purpose: as a reduction of asset costs or a reduction of expenses. Incentives related to the acquisition or construction of fixed assets are recognized as a reduction in the carrying amounts of the related assets and as a reduction to depreciation expense over the useful lives of the assets. Incentives related to specific operating activities are offset against the related expense in the period the expense is incurred. Government incentives received prior to being earned are recognized in current or noncurrent deferred income, whereas government incentives earned prior to being received are recognized in current or noncurrent receivables. Cash received from government incentives related to operating expenses is included as an operating activity in the statement of cash flows, whereas cash received from incentives related to the acquisition of property, plant, and equipment is included as an investing activity.
Inventories	Inventories Inventories are stated at the lower of cost or net realizable value, with cost being determined on a FIFO basis. Cost includes depreciation, labor, material, and overhead costs, including product and process technology costs. Determining net realizable value of finished goods and work in process inventories requires projecting future average selling prices, sales volumes, and costs per part. When net realizable value is below cost, we record a charge to cost of goods sold to write down inventories to their estimated net realizable value in advance of when inventories are actually sold. We review the major characteristics of product type and markets in determining the unit of account for which we perform the lower of cost or net realizable value analysis and categorize all inventories (including DRAM, NAND, and other memory) as a single group.
Leases	Leases We determine if an arrangement is a lease, or contains a lease, at the inception of the arrangement and evaluate whether the lease is an operating lease or a finance lease at the commencement date. We recognize right-of-use assets and lease liabilities for operating and finance leases with terms greater than 12 months. Right-of-use assets represent our right to use an asset for the lease term, while lease liabilities represent our obligation to make lease payments. We do not separate lease and non-lease components for real-estate and gas plant leases. Sublease income is included within lease expense.
Product and Process Technology	Product and Process Technology Costs incurred to (1) acquire product and process technology, (2) patent technology, and (3) keep patents in force, are capitalized and amortized on a straight-line basis over periods ranging up to 12.5 years. We capitalize a portion of costs incurred to patent technology based on historical data of patents issued as a percent of patents we file. Product and process technology costs are amortized over the shorter of (1) the estimated useful life of the technology, (2) the patent term, or (3) the term of the technology agreement. Fully-amortized assets are removed from product and process technology and accumulated amortization.
Product Warranty	Product Warranty We generally provide a limited warranty that our products are in compliance with applicable specifications existing at the time of delivery. Under our standard terms and conditions of sale, liability for certain failures of product during a stated warranty period is usually limited to repair or replacement of defective items or return of, or a credit with respect to, amounts paid for such items. Under certain circumstances, we provide more extensive limited warranty coverage than that provided under our standard terms and conditions. Our warranty obligations are not material.
Property, Plant, and Equipment	Property, Plant, and Equipment Property, plant, and equipment is stated at cost and depreciated using the straight-line method over estimated useful lives of generally 10 to 30 years for buildings, 7 years for production equipment, up to 7 years for other equipment, and 3 to 5 years for software. Assets held for sale are carried at the lower of estimated fair value or carrying value and are included in current assets. When property, plant, or equipment is retired or otherwise disposed, the net book value is removed and we recognize any gain or loss in results of operations. We capitalize interest on borrowings during the period of time we carry out the activities necessary to bring assets to the condition of their intended use and location. We utilize a weighted average capitalization rate that is based on our consolidated debt portfolio. Capitalized interest becomes part of the cost of assets.
Interest Capitalization	We capitalize interest on borrowings during the period of time we carry out the activities necessary to bring assets to the condition of their intended use and location. We utilize a weighted average capitalization rate that is based on our consolidated debt portfolio. Capitalized interest becomes part of the cost of assets.
Research and Development	Research and Development Costs related to the conceptual formulation and design of products and processes are charged to R&D expense as incurred. Development of a product is deemed complete when it is qualified through reviews and tests for performance and reliability. Subsequent to product qualification, product costs are included in cost of goods sold.
Revenue Recognition	Revenue Recognition Revenue is primarily recognized at a point in time when control of the promised goods is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods. Contracts with our customers are generally short-term in duration at fixed, negotiated prices with payment generally due shortly after delivery. We estimate a liability for returns using the expected value method based on historical returns. In addition, we generally offer price protection to our distributors, which is a form of variable consideration that decreases the transaction price. We use the expected value method, based on historical price adjustments and current pricing trends, to estimate the amount of revenue recognized from sales to distributors. Differences between the estimated and actual amounts are recognized as adjustments to revenue.
Stock-based Compensation	Stock-based Compensation Stock-based compensation is measured at the grant date, based on the fair value of the award, and recognized as expense under the straight-line attribution method over the requisite service period. We account for forfeitures as they occur. We issue new shares upon the exercise of stock options, conversion of share units, or issuance of shares under our ESPP.
Treasury Stock	Treasury Stock Treasury stock is carried at cost. When we retire our treasury stock, any excess of the repurchase price paid over par value is allocated between additional capital and retained earnings.
Use of Estimates	Use of Estimates The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that we believe to be reasonable under the circumstances. Estimates and judgments may differ under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis. Actual results could differ from estimates.

Segment Reporting (Policies)

Segment Reporting (Policies)	12 Months Ended
	Aug. 29, 2024
Segment Reporting [Abstract]
Segment Reporting Policy	Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating income and expenses are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments.

Cash and Investments (Tables)

Cash and Investments (Tables)	12 Months Ended
	Aug. 29, 2024
Investments and Cash [Abstract]
Cash and Investments	All of our short-term investments and long-term marketable investments were classified as available-for-sale as of the dates noted below. Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows: As of August 29, 2024 As of August 31, 2023 Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash $ 6,654 $ — $ — $ 6,654 $ 5,771 $ — $ — $ 5,771 Level 1 (2) Money market funds 20 — — 20 1,629 — — 1,629 Level 2 (3) Certificates of deposit 316 6 — 322 1,172 25 — 1,197 Corporate bonds — 771 571 1,342 — 737 437 1,174 Asset-backed securities — 46 433 479 — 15 387 402 Commercial paper 16 160 — 176 — 109 — 109 Government securities 35 82 42 159 5 131 20 156 7,041 $ 1,065 $ 1,046 $ 9,152 8,577 $ 1,017 $ 844 $ 10,438 Restricted cash (4) 11 79 Cash, cash equivalents, and restricted cash $ 7,052 $ 8,656 (1) The maturities of long-term marketable investments primarily range from one five years, except for asset-backed securities which are not due at a single maturity date. (2) The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. (3) The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of August 29, 2024 or August 31, 2023. (4)
Cash and Equivalents and the Fair Values of Available-for-sale Investments	All of our short-term investments and long-term marketable investments were classified as available-for-sale as of the dates noted below. Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows: As of August 29, 2024 As of August 31, 2023 Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash $ 6,654 $ — $ — $ 6,654 $ 5,771 $ — $ — $ 5,771 Level 1 (2) Money market funds 20 — — 20 1,629 — — 1,629 Level 2 (3) Certificates of deposit 316 6 — 322 1,172 25 — 1,197 Corporate bonds — 771 571 1,342 — 737 437 1,174 Asset-backed securities — 46 433 479 — 15 387 402 Commercial paper 16 160 — 176 — 109 — 109 Government securities 35 82 42 159 5 131 20 156 7,041 $ 1,065 $ 1,046 $ 9,152 8,577 $ 1,017 $ 844 $ 10,438 Restricted cash (4) 11 79 Cash, cash equivalents, and restricted cash $ 7,052 $ 8,656 (1) The maturities of long-term marketable investments primarily range from one five years, except for asset-backed securities which are not due at a single maturity date. (2) The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. (3) The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of August 29, 2024 or August 31, 2023. (4)

Receivables (Tables)

Receivables (Tables)	12 Months Ended
	Aug. 29, 2024
Receivables [Abstract]
Schedule of Receivables	As of August 29, August 31, Trade receivables $ 5,419 $ 2,048 Government incentives 834 105 Income and other taxes 268 194 Other 94 96 $ 6,615 $ 2,443

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Aug. 29, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories	As of August 29, August 31, Finished goods $ 1,308 $ 1,616 Work in process 6,774 6,111 Raw materials and supplies 793 660 $ 8,875 $ 8,387

Property, Plant, and Equipment

Property, Plant, and Equipment (Tables)	12 Months Ended
	Aug. 29, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant, and Equipment	As of August 29, August 31, Land $ 284 $ 283 Buildings 20,141 17,967 Equipment (1) 70,813 65,555 Construction in progress (2) 3,444 2,464 Software 1,365 1,316 96,047 87,585 Accumulated depreciation (56,298) (49,657) $ 39,749 $ 37,928 (1) Includes costs related to equipment not placed into service of $3.10 billion as of August 29, 2024 and $2.91 billion as of August 31, 2023. (2) Primarily includes building-related construction and tool installation.

Leases (Tables)

Leases (Tables)	12 Months Ended
	Aug. 29, 2024
Leases [Abstract]
Schedule of Components of Lease Expense	For the year ended 2024 2023 2022 Finance lease cost Amortization of right-of-use asset $ 176 $ 105 $ 99 Interest on lease liability 70 24 24 Operating lease cost (1) 140 137 125 $ 386 $ 266 $ 248
Schedule of Other Lease Information	Supplemental cash flow information related to leases was as follows: For the year ended 2024 2023 2022 Cash flows used for operating activities Finance leases $ 61 $ 24 $ 23 Operating leases 132 139 110 Cash flows used for financing activities – Finance leases 155 109 103 Noncash acquisitions of right-of-use assets Finance leases 905 508 309 Operating leases 54 57 197 Supplemental balance sheet information related to leases was as follows: As of August 29, August 31, Finance lease right-of-use assets (included in property, plant, and equipment) $ 2,038 $ 1,311 Current operating lease liabilities (included in accounts payable and accrued expenses) 71 66 Weighted-average remaining lease term (in years) Finance leases 8 9 Operating leases 10 11 Weighted-average discount rate Finance leases 4.91 % 3.86 % Operating leases 3.42 % 3.21 %
Schedule of Finance Lease Maturities	Finance Leases Operating Leases 2025 $ 400 $ 93 2026 380 82 2027 373 87 2028 362 82 2029 279 76 2030 and thereafter 568 398 Less imputed interest (308) (137) $ 2,054 $ 681
Schedule of Operating Lease Maturities	Finance Leases Operating Leases 2025 $ 400 $ 93 2026 380 82 2027 373 87 2028 362 82 2029 279 76 2030 and thereafter 568 398 Less imputed interest (308) (137) $ 2,054 $ 681

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Aug. 29, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	As of August 29, 2024 As of August 31, 2023 Gross Accumulated Net Carrying Amount Gross Accumulated Net Carrying Amount Product and process technology $ 683 $ (278) $ 405 $ 613 $ (209) $ 404 Other 11 — 11 — — — $ 694 $ (278) $ 416 $ 613 $ (209) $ 404

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
	Aug. 29, 2024
Payables and Accruals [Abstract]
Schedule of Accounts Payable And Accrued Expenses	As of August 29, August 31, Accounts payable $ 2,726 $ 1,725 Property, plant, and equipment 2,925 1,419 Salaries, wages, and benefits 1,117 367 Income and other taxes 218 67 Other 313 380 $ 7,299 $ 3,958

Debt (Tables)

Debt (Tables)	12 Months Ended
	Aug. 29, 2024
Debt Disclosure [Abstract]
Schedule of Debt	As of August 29, 2024 As of August 31, 2023 Net Carrying Amount Net Carrying Amount Stated Rate Effective Rate Principal Current Long-Term Total Principal Current Long-Term Total 2026 Term Loan A 6.819 % 6.95 % $ 922 $ 49 $ 872 $ 921 $ 971 $ 49 $ 921 $ 970 2027 Term Loan A 6.944 % 7.08 % 1,065 57 1,006 1,063 1,123 57 1,063 1,120 2026 Notes 4.975 % 5.07 % 500 — 499 499 500 — 499 499 2027 Notes (1) 4.185 % 4.27 % 900 — 838 838 900 — 798 798 2028 Notes 5.375 % 5.52 % 600 — 597 597 600 — 596 596 2029 A Notes 5.327 % 5.40 % 700 — 698 698 700 — 697 697 2029 B Notes 6.750 % 6.54 % 1,250 — 1,261 1,261 1,250 — 1,263 1,263 2030 Notes 4.663 % 4.73 % 850 — 847 847 850 — 846 846 2031 Notes 5.300 % 5.41 % 1,000 — 994 994 — — — — 2032 Green Bonds 2.703 % 2.77 % 1,000 — 996 996 1,000 — 995 995 2033 A Notes 5.875 % 5.96 % 750 — 745 745 750 — 745 745 2033 B Notes 5.875 % 6.01 % 900 — 891 891 900 — 890 890 2041 Notes 3.366 % 3.41 % 500 — 497 497 500 — 497 497 2051 Notes 3.477 % 3.52 % 500 — 496 496 500 — 496 496 2024 Term Loan A N/A N/A — — — — 588 — 587 587 2025 Term Loan A N/A N/A — — — — 1,052 — 1,050 1,050 Finance lease obligations N/A 4.91 % 2,054 325 1,729 2,054 1,281 172 1,109 1,281 $ 13,491 $ 431 $ 12,966 $ 13,397 $ 13,465 $ 278 $ 13,052 $ 13,330 (1) SOFR
Schedule of Debt Activity	The table below presents the effects of debt financing and prepayment activities in 2024: Transaction Date Increase (Decrease) in Principal Increase (Decrease) in Carrying Value Increase (Decrease) in Cash Issuances 2031 Notes January 12, 2024 $ 1,000 $ 993 $ 993 Prepayments 2024 Term Loan A January 12, 2024 (588) (587) (588) 2025 Term Loan A January 12, 2024 (402) (401) (402) 2025 Term Loan A May 29, 2024 (650) (649) (650) $ (640) $ (644) $ (647)
Schedule of Maturities of Notes Payable	As of August 29, 2024, maturities of notes payable by fiscal year were as follows: 2025 $ 107 2026 607 2027 1,780 2028 1,493 2029 700 2030 and thereafter 6,750 Unamortized issuance costs, discounts, and premium, net (34) Hedge accounting fair value adjustment (60) $ 11,343

Equity (Tables)

Equity (Tables)	12 Months Ended
	Aug. 29, 2024
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	Gains (Losses) on Derivative Instruments Unrealized Gains (Losses) on Investments Pension Liability Adjustments Cumulative Foreign Currency Translation Adjustment Total As of August 31, 2023 $ (304) $ (41) $ 36 $ (3) $ (312) Other comprehensive income (loss) before reclassifications 34 33 7 — 74 Amount reclassified out of accumulated other comprehensive income (loss) 172 — (3) — 169 Tax effects (64) — (1) — (65) Other comprehensive income (loss) 142 33 3 — 178 As of August 29, 2024 $ (162) $ (8) $ 39 $ (3) $ (134)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Aug. 29, 2024
Fair Value Disclosures [Abstract]
Estimated Fair Value and Carrying Value of Debt Instruments	As of August 29, 2024 As of August 31, 2023 Fair Carrying Fair Carrying Notes $ 11,316 $ 11,343 $ 11,549 $ 12,049

Derivative Instruments (Tables)

Derivative Instruments (Tables)	12 Months Ended
	Aug. 29, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments	Notional or Contractual Amount Fair Value (1) of Assets (2) Liabilities (3) As of August 29, 2024 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 3,724 $ 57 $ (71) Cash flow commodity hedges 471 20 (7) Fair value currency hedges 2,511 — (41) Fair value interest rate hedges 900 — (60) Derivative instruments without hedge accounting designation Non-designated currency hedges 2,393 18 (3) $ 95 $ (182) As of August 31, 2023 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 3,873 $ 16 $ (180) Cash flow commodity hedges 331 45 — Fair value interest rate hedges 900 — (100) Derivative instruments without hedge accounting designation Non-designated currency hedges 1,839 2 (17) $ 63 $ (297) (1) Forward and swap contracts are measured at fair value based on market-based observable inputs including market spot and forward rates, interest rates, and credit-risk spreads (Level 2). (2) Included in receivables and other noncurrent assets. (3) Included in accounts payable and accrued expenses and other noncurrent liabilities.
Schedule of Gains and Losses on Derivatives	For the year ended 2024 2023 2022 Gain (loss) from cash flow hedges in accumulated other comprehensive income (loss) $ 33 $ 30 $ (735) Gain (loss) excluded from effectiveness testing in cost of goods sold (135) (101) (32) Gain (loss) reclassified from accumulated other comprehensive income (loss) to earnings, primarily to cost of goods sold (172) (261) (53)

Equity Compensation Plans (Tabl

Equity Compensation Plans (Tables)	12 Months Ended
	Aug. 29, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Restricted Stock Awards Activity	Number of Shares Weighted-Average Grant Date Fair Value Per Share Outstanding as of August 31, 2023 29 $ 59.11 Granted 13 72.72 Vested (12) 57.92 Forfeited (2) 60.42 Outstanding as of August 29, 2024 28 65.82 For the year ended 2024 2023 2022 Restricted stock award shares granted 13 17 13 Weighted-average grant-date fair value per share $ 72.72 $ 55.99 $ 70.81 Aggregate vesting-date fair value of shares vested $ 1,008 $ 514 $ 498
Employee Stock Purchase Plan Valuation Assumptions	For the year ended 2024 2023 2022 Weighted-average grant-date fair value per share $ 26.82 $ 17.06 $ 18.87 Average expected life in years 0.5 0.5 0.5 Weighted-average expected volatility (based on implied volatility) 41 % 37 % 43 % Weighted-average risk-free interest rate 5.2 % 5.1 % 2.0 % Expected dividend yield 0.5 % 0.7 % 0.6 %
Stock-based Compensation Expense	For the year ended 2024 2023 2022 Stock-based compensation expense by caption Cost of goods sold $ 312 $ 201 $ 193 Research and development 296 226 175 Selling, general, and administrative 213 137 133 Restructure — (7) (5) $ 821 $ 557 $ 496 Stock-based compensation expense by type of award Restricted stock awards $ 749 $ 488 $ 429 ESPP 72 69 66 Stock options — — 1 $ 821 $ 557 $ 496

Government Incentives (Tables)

Government Incentives (Tables)	12 Months Ended
	Aug. 29, 2024
Government Assistance [Abstract]
Schedule of Balance Sheet Line Items affected by Government Incentives	The line items on the balance sheet affected by government incentives were as follows: As of August 29, Receivables $ 834 Other noncurrent assets 188 Noncurrent unearned government incentives 550

Revenue and Customer Contract_2

Revenue and Customer Contract Liabilities (Tables)	12 Months Ended
	Aug. 29, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	For the year ended 2024 2023 2022 DRAM $ 17,603 $ 10,978 $ 22,386 NAND 7,227 4,206 7,811 Other (primarily NOR) 281 356 561 $ 25,111 $ 15,540 $ 30,758

Restructure and Asset Impairm_2

Restructure and Asset Impairments (Tables)	12 Months Ended
	Aug. 29, 2024
Restructuring and Related Activities [Abstract]
Restructure and Asset Impairments	For the year ended 2024 2023 2022 Employee severance $ 1 $ 163 $ — Asset impairments and other asset-related costs — 14 63 Other — (6) (15) $ 1 $ 171 $ 48

Other Operating (Income) Expe_2

Other Operating (Income) Expense, Net (Tables)	12 Months Ended
	Aug. 29, 2024
Other Income and Expenses [Abstract]
Schedule of Other Operating (Income) Expense, Net	For the year ended 2024 2023 2022 Patent cross-license agreement gain $ (200) $ — $ — (Gain) loss on disposition of property, plant, and equipment (59) (54) (41) Goodwill impairment — 101 — Litigation settlement — 68 — Other 8 9 7 $ (251) $ 124 $ (34)

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Aug. 29, 2024
Income Tax Disclosure [Abstract]
Schedule of Income (loss) Before Tax and Other Items	Our income tax (provision) benefit consisted of the following: For the year ended 2024 2023 2022 Income (loss) before income taxes and equity in net income (loss) of equity method investees U.S. $ 544 $ 235 $ 112 Foreign 696 (5,893) 9,459 $ 1,240 $ (5,658) $ 9,571 Income tax (provision) benefit Current U.S. federal $ (82) $ (5) $ (65) State (1) (1) (1) Foreign (333) (178) (528) (416) (184) (594) Deferred U.S. federal 18 (84) (166) State — — (225) Foreign (53) 91 97 (35) 7 (294) Income tax (provision) benefit $ (451) $ (177) $ (888)
Schedule of Components of Income Tax (Provision) Benefit	Our income tax (provision) benefit consisted of the following: For the year ended 2024 2023 2022 Income (loss) before income taxes and equity in net income (loss) of equity method investees U.S. $ 544 $ 235 $ 112 Foreign 696 (5,893) 9,459 $ 1,240 $ (5,658) $ 9,571 Income tax (provision) benefit Current U.S. federal $ (82) $ (5) $ (65) State (1) (1) (1) Foreign (333) (178) (528) (416) (184) (594) Deferred U.S. federal 18 (84) (166) State — — (225) Foreign (53) 91 97 (35) 7 (294) Income tax (provision) benefit $ (451) $ (177) $ (888)
Schedule of Effective Income Tax Reconciliation	The table below reconciles our tax (provision) benefit based on the U.S. federal statutory rate to our effective rate: For the year ended 2024 2023 2022 U.S. federal income tax (provision) benefit at statutory rate $ (260) 21.0 % $ 1,188 21.0 % $ (2,010) 21.0 % U.S. tax on foreign operations (7) 0.6 6 0.1 (322) 3.4 Change in valuation allowance (59) 4.8 (50) (0.9) (241) 2.5 Change in unrecognized tax benefits (41) 3.3 (30) (0.5) (67) 0.7 Foreign tax rate differential (214) 17.2 (1,285) (22.8) 1,601 (16.7) Research and development tax credits 76 (6.1) 43 0.8 66 (0.7) State taxes, net of federal benefit 12 (1.0) 37 0.7 — — Other 42 (3.4) (86) (1.5) 85 (0.9) Income tax (provision) benefit $ (451) 36.4 % $ (177) (3.1) % $ (888) 9.3 %
Schedule of Deferred Tax Assets and Liabilities	As of August 29, August 31, Deferred tax assets Net operating loss and tax credit carryforwards $ 1,050 $ 1,112 Accrued salaries, wages, and benefits 182 39 Operating lease liabilities 175 135 Inventories 4 52 Other 59 75 Gross deferred tax assets 1,470 1,413 Less valuation allowance (593) (528) Deferred tax assets, net of valuation allowance 877 885 Deferred tax liabilities Right-of-use assets (152) (115) Property, plant, and equipment (194) (31) Other (70) (100) Deferred tax liabilities (416) (246) Net deferred tax assets $ 461 $ 639 Reported as Deferred tax assets $ 520 $ 756 Deferred tax liabilities (included in other noncurrent liabilities) (59) (117) Net deferred tax assets $ 461 $ 639
Schedule of Net Operating Loss Carryforwards	As of August 29, 2024, our net operating loss carryforward amounts and expiration periods, as reported to tax authorities, were as follows: Year of Expiration Malaysia Singapore State Japan Other Total 2025 - 2029 $ — $ — $ 47 $ 144 $ 3 $ 194 2030 - 2034 — — 298 325 126 749 2035 - 2039 — — 285 — — 285 2040 - 2044 — — 94 — — 94 Indefinite 1,224 765 — — — 1,989 $ 1,224 $ 765 $ 724 $ 469 $ 129 $ 3,311
Schedule of Tax Credit Carryforwards	As of August 29, 2024, our tax credit carryforward amounts and expiration periods, as reported to tax authorities, were as follows: Year of Tax Credit Expiration U.S. Federal State Other Total 2025 - 2029 $ — $ 61 $ — $ 61 2030 - 2034 47 134 2 183 2035 - 2039 48 140 44 232 2040 - 2045 315 6 — 321 Indefinite — 145 — 145 $ 410 $ 486 $ 46 $ 942
Schedule of Unrecognized Tax Benefits Rollforward	Below is a reconciliation of the beginning and ending amount of our unrecognized tax benefits: For the year ended 2024 2023 2022 Beginning unrecognized tax benefits $ 744 $ 731 $ 660 Increases related to tax positions from prior years 2 2 14 Increases related to prior year tax positions taken in current year 20 27 — Increases related to tax positions taken in current year 54 17 80 Decreases related to tax positions from prior years (89) (33) (23) Decreases related to settlement with tax authorities (15) — — Ending unrecognized tax benefits $ 716 $ 744 $ 731

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Aug. 29, 2024
Earnings Per Share [Abstract]
Basic and Diluted Earnings Per Share	For the year ended 2024 2023 2022 Net income (loss) – Basic and Diluted $ 778 $ (5,833) $ 8,687 Weighted-average common shares outstanding – Basic 1,105 1,093 1,112 Dilutive effect of equity compensation plans 13 — 10 Weighted-average common shares outstanding – Diluted 1,118 1,093 1,122 Earnings (loss) per share Basic $ 0.70 $ (5.34) $ 7.81 Diluted 0.70 (5.34) 7.75
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Antidilutive potential common shares excluded from the computation of diluted earnings per share, that could dilute basic earnings per share in the future, were as follows at the end of the periods shown: For the year ended 2024 2023 2022 Equity compensation plans 3 33 5

Segment and Other Information (

Segment and Other Information (Tables)	12 Months Ended
	Aug. 29, 2024
Segment Reporting [Abstract]
Schedule of Results by Segment	For the year ended 2024 2023 2022 Revenue CNBU $ 9,513 $ 5,710 $ 13,693 MBU 6,354 3,630 7,260 EBU 4,614 3,637 5,235 SBU 4,592 2,553 4,553 All Other 38 10 17 Total revenue $ 25,111 $ 15,540 $ 30,758 Operating income (loss) CNBU $ 980 $ (585) $ 5,844 MBU 114 (1,750) 2,160 EBU 199 382 1,752 SBU (362) (1,887) 513 All Other 17 8 12 948 (3,832) 10,281 Unallocated Lower costs from sale of inventory written down in prior periods 987 844 — Patent cross-license agreement 200 — — Stock-based compensation (821) (564) (501) Restructure and asset impairment (1) (171) (48) Provision to write down inventories to net realizable value — (1,831) — Goodwill impairment — (101) — Litigation settlement — (68) — Other (9) (22) (30) 356 (1,913) (579) Total operating income (loss) $ 1,304 $ (5,745) $ 9,702 Depreciation and amortization expense included in operating income (loss) was as follows: For the year ended 2024 2023 2022 CNBU $ 2,760 $ 2,512 $ 2,766 MBU 2,002 2,149 1,725 EBU 1,491 1,324 1,280 SBU 1,501 1,751 1,323 All Other 8 1 2 Unallocated 18 19 20 $ 7,780 $ 7,756 $ 7,116

Certain Concentrations (Tables)

Certain Concentrations (Tables)	12 Months Ended
	Aug. 29, 2024
Risks and Uncertainties [Abstract]
Schedule of Market Concentration Risk	Revenue by market segment as a percent of total revenue, rounded to the nearest 5%, is presented in the table below: For the year ended 2024 2023 2022 Data center and networking 35 % 25 % 35 % Mobile 25 % 25 % 25 % PC, graphics, and other 25 % 30 % 25 % Intelligent edge – automotive, industrial, and consumer embedded 20 % 25 % 15 % Percentages of total revenue may not total 100% due to rounding.

Geographic Information (Tables)

Geographic Information (Tables)	12 Months Ended
	Aug. 29, 2024
Segment Reporting [Abstract]
Geographic Revenue from Contracts with Customers based on Location of Customer Headquarters	Revenue based on the geographic location of our customers’ headquarters was as follows: For the year ended 2024 2023 2022 United States $ 13,168 $ 7,805 $ 16,026 Taiwan 4,708 2,697 6,185 Mainland China (excluding Hong Kong) 3,045 2,181 3,311 Other Asia Pacific 1,330 752 1,223 Hong Kong 1,071 340 1,665 Japan 840 987 1,696 Europe 818 682 505 Other 131 96 147 $ 25,111 $ 15,540 $ 30,758
Long-lived Assets by Geographic Area	Long-lived assets by geographic area consisted of property, plant, and equipment and operating lease right-of-use assets and were as follows: As of August 29, August 31, Taiwan $ 14,156 $ 12,926 Singapore 10,588 11,283 Japan 7,085 7,323 United States 6,508 5,196 Malaysia 1,153 1,124 China 486 395 India 338 277 Other 80 70 $ 40,394 $ 38,594

Schedule II Valuation and Qua_2

Schedule II Valuation and Qualifying Accounts (Tables)	12 Months Ended
	Aug. 29, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Deferred Tax Asset Valuation Allowance	Balance at Charged Currency Balance at Deferred Tax Asset Valuation Allowance Year ended August 29, 2024 $ 528 $ 57 $ 8 $ 593 Year ended August 31, 2023 471 58 (1) 528 Year ended September 1, 2022 233 241 (3) 471

Significant Accounting Polici_3

Significant Accounting Policies - Product and Process Technology (Details)	Aug. 29, 2024
Maximum
Finite-Lived Intangible Assets [Line Items]
Maximum life of product and process technology intangible assets (in years)	12 years 6 months

Significant Accounting Polici_4

Significant Accounting Policies - Property, Plant and Equipment (Details)	Aug. 29, 2024
Buildings | Minimum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	10 years
Buildings | Maximum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	30 years
Production Equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	7 years
Other Equipment | Maximum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	7 years
Software | Minimum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	3 years
Software | Maximum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	5 years

Variable Interest Entities (Det

Variable Interest Entities (Details) - USD ($) $ in Millions	Aug. 29, 2024	Aug. 31, 2023
Variable Interest Entity [Line Items]
Finance Lease Right-of-Use Asset	$ 2,038	$ 1,311
Finance Lease Liability	2,054	$ 1,281
Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Finance Lease Right-of-Use Asset	680
Finance Lease Liability	$ 680

Cash and Investments (Details)

Cash and Investments (Details) - USD ($) $ in Millions		Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022	Sep. 02, 2021
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents		$ 7,041	$ 8,577
Short-term Investments		1,065	1,017
Long-term Marketable Investments	[1]	1,046	844
Total Fair Value		9,152	10,438
Restricted cash	[2]	11	79
Cash, cash equivalents, and restricted cash		$ 7,052	8,656	$ 8,339	$ 7,829
Minimum
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-sale, Term, Noncurrent		1 year
Maximum
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-sale, Term, Noncurrent		5 years
Cash
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents		$ 6,654	5,771
Short-term Investments		0	0
Long-term Marketable Investments		0	0
Total Fair Value		6,654	5,771
Money market funds | Level 1
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[3]	20	1,629
Short-term Investments	[3]	0	0
Long-term Marketable Investments	[1],[3]	0	0
Total Fair Value	[3]	20	1,629
Certificates of deposit | Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	316	1,172
Short-term Investments	[4]	6	25
Long-term Marketable Investments	[1],[4]	0	0
Total Fair Value	[4]	322	1,197
Corporate bonds | Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	0	0
Short-term Investments	[4]	771	737
Long-term Marketable Investments	[1],[4]	571	437
Total Fair Value	[4]	1,342	1,174
Asset-backed securities | Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	0	0
Short-term Investments	[4]	46	15
Long-term Marketable Investments	[1],[4]	433	387
Total Fair Value	[4]	479	402
Commercial paper | Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	16	0
Short-term Investments	[4]	160	109
Long-term Marketable Investments	[1],[4]	0	0
Total Fair Value	[4]	176	109
Government securities | Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	35	5
Short-term Investments	[4]	82	131
Long-term Marketable Investments	[1],[4]	42	20
Total Fair Value	[4]	$ 159	$ 156
[1] The maturities of long-term marketable investments primarily range from one five years, except for asset-backed securities which are not due at a single maturity date. Restricted cash is included in other current assets and other noncurrent assets and primarily relates to certain government incentives received prior to being earned and for which restrictions lapse upon achieving certain performance conditions or which will be returned if performance conditions are not met. The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of August 29, 2024 or August 31, 2023.

Cash and Investments - Non-mark

Cash and Investments - Non-marketable Equity Investments (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Equity Securities without Readily Determinable Fair Value [Line Items]
Non-marketable Equity Investments without Readily Determinable Fair Value, Impairment Loss, Annual Amount	$ (32)	$ (7)
Non-marketable Equity Investments without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount			$ 36
Fair Value, Inputs, Level 3
Equity Securities without Readily Determinable Fair Value [Line Items]
Non-marketable Equity Investments without Readily Determinable Fair Value, Amount	$ 190	$ 218

Receivables (Details)

Receivables (Details) - USD ($) $ in Millions	Aug. 29, 2024	Aug. 31, 2023
Receivables [Abstract]
Trade receivables	$ 5,419	$ 2,048
Government incentives	834	105
Income and other taxes	268	194
Other	94	96
Receivables	$ 6,615	$ 2,443

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Finished goods	$ 1,308	$ 1,616
Work in process	6,774	6,111
Raw materials and supplies	793	660
Inventories	8,875	8,387
Provision to write down inventories to net realizable value	$ 0	$ 1,831	$ 0

Property, Plant, and Equipmen_2

Property, Plant, and Equipment (Details) - USD ($) $ in Millions		12 Months Ended
		Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		$ 96,047	$ 87,585
Accumulated depreciation		(56,298)	(49,657)
Property, plant, and equipment, net		39,749	37,928
Depreciation
Depreciation expense		7,700	7,670	$ 7,030
Capitalized Interest
Interest capitalized as part of the cost of property, plant, and equipment		225	208	$ 77
Land
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		284	283
Buildings
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		20,141	17,967
Equipment
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross	[1]	70,813	65,555
Equipment not placed into service
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		3,100	2,910
Construction in progress
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross	[2]	3,444	2,464
Software
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		$ 1,365	$ 1,316
[1] Includes costs related to equipment not placed into service of $3.10 billion as of August 29, 2024 and $2.91 billion as of August 31, 2023. Primarily includes building-related construction and tool installation.

Leases - Cost and Cash Flows (D

Leases - Cost and Cash Flows (Details) - USD ($) $ in Millions		12 Months Ended
		Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Components of Lease Expense
Amortization of right-of-use asset		$ 176	$ 105	$ 99
Interest on lease liability		70	24	24
Operating lease cost(1)	[1]	140	137	125
Total lease cost		386	266	248
Cash flows used for operating activities
Finance leases		61	24	23
Operating leases		132	139	110
Cash flows used for financing activities
Cash flows used for financing activities – Finance leases		155	109	103
Finance leases, noncash acquisitions of right-of-use assets		905	508	309
Operating leases, noncash acquisitions of right-of-use assets		$ 54	$ 57	$ 197
Lessee, Finance Lease Description
Finance Lease Right-of-Use Asset, Balance Sheet Location		Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization
Finance lease right-of-use assets (included in property, plant, and equipment)		$ 2,038	$ 1,311
Finance leases, Weighted-average remaining lease term (in years)		8 years	9 years
Finance leases, Weighted-average discount rate		4.91%	3.86%
Lessee, Operating Lease Description
Operating Lease Liability, Balance Sheet Location		Accounts payable and accrued expenses	Accounts payable and accrued expenses
Current operating lease liabilities (included in accounts payable and accrued expenses)		$ 71	$ 66
Operating leases, Weighted-average remaining lease term (in years)		10 years	11 years
Operating leases, Weighted-average discount rate		3.42%	3.21%
Real Estate | Minimum
Lessee, Lease, Description [Line Items]
Operating lease renewal term		1 year
Real Estate | Maximum
Lessee, Lease, Description [Line Items]
Operating lease renewal term		10 years
Land | Minimum
Lessee, Lease, Description [Line Items]
Operating lease renewal term		1 year
Land | Maximum
Lessee, Lease, Description [Line Items]
Operating lease renewal term		99 years
[1] Operating lease cost includes short-term and variable lease expenses, which were not material for the periods presented.

Leases - Maturities (Details)

Leases - Maturities (Details) - USD ($) $ in Millions	Aug. 29, 2024	Aug. 31, 2023
Finance Lease Maturities
2025	$ 400
2026	380
2027	373
2028	362
2029	279
2030 and thereafter	568
Less imputed interest	(308)
Finance Lease Liability	2,054	$ 1,281
Operating Lease Maturities
2025	93
2026	82
2027	87
2028	82
2029	76
2030 and thereafter	398
Less imputed interest	(137)
Operating Lease Liability	$ 681

Leases - Not Yet Commenced (Det

Leases - Not Yet Commenced (Details) $ in Millions	Aug. 29, 2024 USD ($)
Financing Lease, Lease Not yet Commenced
Finance Lease Not yet Commenced
Commitments for purchase obligations	$ 835
Weighted Average
Finance Lease Not yet Commenced
Finance lease not yet commenced, lease term	13 years

Intangible Assets (Details)

Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Amortizing assets [Line Items]
Gross Amount	$ 694	$ 613
Accumulated Amortization	(278)	(209)
Net Carrying Amount	416	404
Additions and Amortization
Increase in product and process technology from capitalizations	84	87	$ 158
Amortization of Intangible Assets	82	86	$ 85
Annual amortization expense for intangible assets
2025	67
2026	56
2027	52
2028	49
2029	42
Product and process technology
Amortizing assets [Line Items]
Gross Amount	683	613
Accumulated Amortization	(278)	(209)
Net Carrying Amount	405	404
Other
Amortizing assets [Line Items]
Gross Amount	11	0
Accumulated Amortization	0	0
Net Carrying Amount	$ 11	$ 0
Weighted Average
Additions and Amortization
Useful lives of assets placed into service	10 years	9 years	9 years

Accounts Payable and Accrued _3

Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Millions	Aug. 29, 2024	Aug. 31, 2023
Accounts Payable and Accrued Liabilities, Current [Abstract]
Accounts payable	$ 2,726	$ 1,725
Property, plant, and equipment	2,925	1,419
Salaries, wages, and benefits	1,117	367
Income and other taxes	218	67
Other	313	380
Total accounts payable and accrued expenses	$ 7,299	$ 3,958

Debt - Long-term Debt (Details)

Debt - Long-term Debt (Details) - USD ($) $ in Millions		12 Months Ended
		Aug. 29, 2024	Aug. 31, 2023
Long-term Debt by Current and Noncurrent
Total Long-term Debt		$ 11,343
Finance Lease Effective Rate (in ten thousandths)		4.91%	3.86%
Current Finance Lease Obligations		$ 325	$ 172
Long-Term Finance Lease Obligations		1,729	1,109
Total Finance Lease Obligations		2,054	1,281
Long-term Debt and Lease Obligation
Principal (including finance lease obligation)		13,491	13,465
Current debt (including finance lease obligation)		431	278
Long-term debt (including finance lease obligation)		12,966	13,052
Total Net Carrying Amount of Debt (including finance lease obligation)		$ 13,397	$ 13,330
Current finance lease liability, statement of financial position		Current debt (including finance lease obligation)	Current debt (including finance lease obligation)
Noncurrent finance lease liability, statement of financial position		Long-term debt (including finance lease obligation)	Long-term debt (including finance lease obligation)
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]		Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]
Interest rate swap | Fair value hedges | Designated hedging instruments
Long-term Debt and Lease Obligation
Notional or Contractual Amount		$ 900	$ 900
Spread on 2027 Variable Interest Rate		3.33%
Term Loan | 2026 Term Loan A
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		6.819%
Effective Rate (in ten thousandths)		6.95%
Principal		$ 922	971
Current Portion of Long-term Debt		49	49
Noncurrent Long-Term Debt		872	921
Total Long-term Debt		$ 921	970
Term Loan | 2027 Term Loan A
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		6.944%
Effective Rate (in ten thousandths)		7.08%
Principal		$ 1,065	1,123
Current Portion of Long-term Debt		57	57
Noncurrent Long-Term Debt		1,006	1,063
Total Long-term Debt		1,063	1,120
Term Loan | 2024 Term Loan A
Long-term Debt by Current and Noncurrent
Principal		0	588
Current Portion of Long-term Debt		0	0
Noncurrent Long-Term Debt		0	587
Total Long-term Debt		0	587
Term Loan | 2025 Term Loan A
Long-term Debt by Current and Noncurrent
Principal		0	1,052
Current Portion of Long-term Debt		0	0
Noncurrent Long-Term Debt		0	1,050
Total Long-term Debt		$ 0	1,050
Corporate Bonds | 2026 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		4.975%
Effective Rate (in ten thousandths)		5.07%
Principal		$ 500	500
Current Portion of Long-term Debt		0	0
Noncurrent Long-Term Debt		499	499
Total Long-term Debt		$ 499	499
Corporate Bonds | 2027 Notes(1)
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)	[1]	4.185%
Effective Rate (in ten thousandths)	[1]	4.27%
Principal	[1]	$ 900	900
Current Portion of Long-term Debt	[1]	0	0
Noncurrent Long-Term Debt	[1]	838	798
Total Long-term Debt	[1]	$ 838	798
Corporate Bonds | 2028 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		5.375%
Effective Rate (in ten thousandths)		5.52%
Principal		$ 600	600
Current Portion of Long-term Debt		0	0
Noncurrent Long-Term Debt		597	596
Total Long-term Debt		$ 597	596
Corporate Bonds | 2029 A Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		5.327%
Effective Rate (in ten thousandths)		5.40%
Principal		$ 700	700
Current Portion of Long-term Debt		0	0
Noncurrent Long-Term Debt		698	697
Total Long-term Debt		$ 698	697
Corporate Bonds | 2029 B Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		6.75%
Effective Rate (in ten thousandths)		6.54%
Principal		$ 1,250	1,250
Current Portion of Long-term Debt		0	0
Noncurrent Long-Term Debt		1,261	1,263
Total Long-term Debt		$ 1,261	1,263
Corporate Bonds | 2030 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		4.663%
Effective Rate (in ten thousandths)		4.73%
Principal		$ 850	850
Current Portion of Long-term Debt		0	0
Noncurrent Long-Term Debt		847	846
Total Long-term Debt		$ 847	846
Corporate Bonds | 2031 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		5.30%
Effective Rate (in ten thousandths)		5.41%
Principal		$ 1,000	0
Current Portion of Long-term Debt		0	0
Noncurrent Long-Term Debt		994	0
Total Long-term Debt		$ 994	0
Corporate Bonds | 2032 Green Bonds
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		2.703%
Effective Rate (in ten thousandths)		2.77%
Principal		$ 1,000	1,000
Current Portion of Long-term Debt		0	0
Noncurrent Long-Term Debt		996	995
Total Long-term Debt		$ 996	995
Corporate Bonds | 2033 A Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		5.875%
Effective Rate (in ten thousandths)		5.96%
Principal		$ 750	750
Current Portion of Long-term Debt		0	0
Noncurrent Long-Term Debt		745	745
Total Long-term Debt		$ 745	745
Corporate Bonds | 2033 B Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		5.875%
Effective Rate (in ten thousandths)		6.01%
Principal		$ 900	900
Current Portion of Long-term Debt		0	0
Noncurrent Long-Term Debt		891	890
Total Long-term Debt		$ 891	890
Corporate Bonds | 2041 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		3.366%
Effective Rate (in ten thousandths)		3.41%
Principal		$ 500	500
Current Portion of Long-term Debt		0	0
Noncurrent Long-Term Debt		497	497
Total Long-term Debt		$ 497	497
Corporate Bonds | 2051 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)		3.477%
Effective Rate (in ten thousandths)		3.52%
Principal		$ 500	500
Current Portion of Long-term Debt		0	0
Noncurrent Long-Term Debt		496	496
Total Long-term Debt		$ 496	$ 496
[1] In 2021, we entered into fixed-to-floating interest rate swaps on the 2027 Notes with an aggregate $900 million notional amount equal to the principal amount of the 2027 Notes. The resulting variable interest paid is at a rate equal to SOFR

Debt - Debt Activity (Details)

Debt - Debt Activity (Details) - USD ($) $ in Millions			12 Months Ended
	May 29, 2024	Jan. 12, 2024	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Issuances and Repayments of Debt
Increase (Decrease) Principal			$ (640)	$ 6,700
Increase (Decrease) in Carrying Value			(644)
Increase in Cash - Issuances				6,690
(Decrease) in Cash From Certain Debt Activities, Net			$ (647)
Loss on debt repurchases					$ (83)
Term Loan | 2024 Term Loan A
Issuances and Repayments of Debt
Increase (Decrease) Principal		$ (588)		$ (600)
Increase (Decrease) in Carrying Value		(587)
(Decrease) in Cash - Prepayments		(588)
Term Loan | 2025 Term Loan A
Issuances and Repayments of Debt
Increase (Decrease) Principal	$ (650)	(402)
Increase (Decrease) in Carrying Value	(649)	(401)
(Decrease) in Cash - Prepayments	$ (650)	(402)
Corporate Bonds
Issuances and Repayments of Debt
Increase (Decrease) Principal					(1,850)
(Decrease) in Cash - Prepayments					(1,930)
Corporate Bonds
Issuances and Repayments of Debt
Increase (Decrease) Principal					2,000
Increase in Cash - Issuances					$ 1,990
Corporate Bonds | 2031 Notes
Issuances and Repayments of Debt
Increase (Decrease) Principal		1,000
Increase (Decrease) in Carrying Value		993
Increase in Cash - Issuances		$ 993

Debt Additional Disclosures (De

Debt Additional Disclosures (Details)	12 Months Ended
	Aug. 29, 2024 USD ($) Rate
Revolving Credit Facility
Total Long-term Debt	$ 11,343,000,000
Corporate Bonds
Senior Unsecured Notes
Debt Instrument, Redemption Price Percentage	100%
Debt Covenant, Restricted Subsidiaries, Ownership Percentage by Parent (in hundredths)	80%
Debt Instrument, Redemption Price Percentage, Change in Control Event	101%
Term Loan | Maximum
Term Loans A
Debt Covenant, Ratio Of Total Debt To Adjusted EBITDA | Rate	325%
Debt Instrument, Covenant, Ratio of Total Debt To Adjusted EBITDA, Temporary Increase Following Material Acquisitions | Rate	375%
Term Loan | 2026 Term Loan A and 2027 Term Loan A
Term Loans A
Debt Instrument, Periodic Payment, Percentage of Original Principal	1.25%
Debt Instrument, Covenant Description	The Multi-Tranche Term Loan Agreement requires us to maintain, on a consolidated basis, a leverage ratio of total indebtedness to adjusted EBITDA, as defined in the Multi-Tranche Term Loan Agreement and calculated as of the last day of each fiscal quarter, not to exceed 3.25 to 1.00, subject to a temporary four quarter increase in such ratio to 3.75 to 1.00 following certain material acquisitions. The Multi-Tranche Term Loan Agreement contains other covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our restricted subsidiaries to (1) create or incur certain liens and enter into sale and lease-back transactions, (2) create, assume, incur, or guarantee certain additional secured indebtedness and unsecured indebtedness of our restricted subsidiaries, and (3) consolidate with or merge with or into, or convey, transfer, lease, or otherwise dispose of all or substantially all of our assets, to another entity. These covenants are subject to a number of limitations, exceptions, and qualifications. Our obligations under the Multi-Tranche Term Loan Agreement are unsecured.
Term Loan | 2026 Term Loan A and 2027 Term Loan A | SOFR
Term Loans A
Debt Instrument, Basis Spread on Variable Rate	0.10%
Term Loan | 2026 Term Loan A and 2027 Term Loan A | Minimum | Adjusted term SOFR
Term Loans A
Debt Instrument, Basis Spread on Variable Rate	1%
Term Loan | 2026 Term Loan A and 2027 Term Loan A | Maximum | Adjusted term SOFR
Term Loans A
Debt Instrument, Basis Spread on Variable Rate	2%
Revolving Credit Facility | 2026 Revolving Credit Facility
Term Loans A
Debt Instrument, Covenant Description	The Revolving Credit Facility contains the same leverage ratio and substantially the same other covenants as the Multi-Tranche Term Loan Agreement.
Revolving Credit Facility
Total Long-term Debt	$ 0
Available borrowing capacity	$ 2,500,000,000
Revolving Credit Facility | 2026 Revolving Credit Facility | Minimum | Adjusted term SOFR
Term Loans A
Debt Instrument, Basis Spread on Variable Rate	1%
Revolving Credit Facility | 2026 Revolving Credit Facility | Minimum | SOFR
Term Loans A
Debt Instrument, Basis Spread on Variable Rate	0.11%
Revolving Credit Facility | 2026 Revolving Credit Facility | Maximum | Adjusted term SOFR
Term Loans A
Debt Instrument, Basis Spread on Variable Rate	1.75%
Revolving Credit Facility | 2026 Revolving Credit Facility | Maximum | SOFR
Term Loans A
Debt Instrument, Basis Spread on Variable Rate	0.43%

Debt Maturities (Details)

Debt Maturities (Details) $ in Millions	Aug. 29, 2024 USD ($)
Maturities of Notes Payable
2025	$ 107
2026	607
2027	1,780
2028	1,493
2029	700
2030 and thereafter	6,750
Unamortized issuance costs, discounts, and premium, net	(34)
Hedge accounting fair value adjustment	(60)
Total Long-term Debt	$ 11,343

Commitments (Details)

Commitments (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 31, 2023	Aug. 29, 2024
Goods, Services, and Capital Additions (non-lease)
Unrecorded Unconditional Purchase Obligation, Including Lease Not yet Commenced, Fiscal Year Maturity [Abstract]
Commitments for purchase obligations, due in 2030 and thereafter		$ 1,300
Commitments for purchase obligations, due in 2029		200
Commitments for purchase obligations, due in 2028		800
Commitments for purchase obligations, due in 2025		1,700
Commitments for purchase obligations, due in 2027		1,000
Commitments for purchase obligations, due in 2026		1,700
Commitments for purchase obligations		$ 6,700
Power Purchase Agreement
Unrecorded Unconditional Purchase Obligation, Including Lease Not yet Commenced, Fiscal Year Maturity [Abstract]
Long-Term Power Purchase Commitment, Singapore	18 years

Contingencies (Details)

Contingencies (Details) $ in Millions					12 Months Ended
	Sep. 12, 2024 patent	Sep. 11, 2024 patent	Sep. 06, 2024 patent	Aug. 30, 2024 patent	Aug. 29, 2024 USD ($) patent
Netlist Inc. vs Micron - Complaint 1 | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed					1
Netlist Inc. vs Micron - Complaint 2 | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed					3
Netlist Inc. vs Micron - Complaint 3 | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed					2
Netlist Inc. vs Micron - Complaint 4 | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed					6
Netlist Inc. vs Micron - Complaint 5 | Patent Matters
Loss Contingencies [Line Items]
Number of patents allegedly infringed					1
Netlist Inc. vs Micron - Complaint 5 Amendment | Patent Matters | Expecting Appeal
Loss Contingencies [Line Items]
Number of patents allegedly infringed					2
Number of patents found infringed (jury)					2
Netlist Inc. vs Micron - Complaint 5 Amendment | Patent 7,619,912
Loss Contingencies [Line Items]
Number of patents found unpatentable by US Patent and Trademark Office					1
Netlist Inc. vs Micron - Complaint 5 Amendment | Patent 7,619,912 | Expecting Appeal
Loss Contingencies [Line Items]
Damages awarded to Netlist (jury) | $					$ 425
Netlist Inc. vs Micron - Complaint 5 Amendment | Patent 11,093,417
Loss Contingencies [Line Items]
Number of patents found unpatentable by US Patent and Trademark Office					1
Netlist Inc. vs Micron - Complaint 5 Amendment | Patent 11,093,417 | Expecting Appeal
Loss Contingencies [Line Items]
Damages awarded to Netlist (jury) | $					$ 20
Sonrai Memory, Ltd. vs Micron | Patent Matters | Dismissed Litigation | Subsequent Event
Loss Contingencies [Line Items]
Number of patents allegedly infringed			2
Besang, Inc. vs Micron | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed					1
Yangtze Memory Technologies Company, Ltd. vs Micron - Complaint 1 | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed					8
Yangtze Memory Technologies Company, Ltd. vs Micron - Complaints 2, 3, 4 | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed					3
Yangtze Memory Technologies Company, Ltd. Complaint 5 | Patent Matters | Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed					11
Yangtze Memory Technologies Company, Ltd. Complaint 6_7_8_9_10 | Patent Matters | Pending Litigation | Subsequent Event
Loss Contingencies [Line Items]
Number of patents allegedly infringed		5
MimirIP vs Micron - Complaint 1 | Patent Matters | Dismissed Litigation | Subsequent Event
Loss Contingencies [Line Items]
Number of patents allegedly infringed	6
MimirIP vs Micron - Complaint 2 | Patent Matters | Dismissed Litigation | Subsequent Event
Loss Contingencies [Line Items]
Number of patents allegedly infringed				6
MimirIP vs Micron - Complaint 3 | Patent Matters | Dismissed Litigation | Subsequent Event
Loss Contingencies [Line Items]
Number of patents allegedly infringed				6

Equity - Common Stock Repurchas

Equity - Common Stock Repurchases and Dividends (Details) - USD ($) $ / shares in Units, shares in Millions		3 Months Ended				12 Months Ended			72 Months Ended
	Sep. 25, 2024	Aug. 29, 2024	May 30, 2024	Feb. 29, 2024	Nov. 30, 2023	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022	Aug. 29, 2024
Common Stock Repurchases
Payments for Repurchase of Common Stock						$ 300,000,000	$ 425,000,000	$ 2,432,000,000
Dividends
Cash dividends declared (per share)						$ 0.460	$ 0.460	$ 0.315
Payments of dividends to shareholders (per share)		$ 0.115	$ 0.115	$ 0.115	$ 0.115
Subsequent Event | O2025Q1 Dividends
Dividends
Cash dividends declared (per share)	$ 0.115
Dividends Payable, Date to be Paid	Oct. 23, 2024
Dividends Payable, Date of Record	Oct. 07, 2024
Repurchases Authorized by the BOD
Common Stock Repurchases
Common Stock Repurchase, Authorized Amount		$ 10,000,000,000				$ 10,000,000,000			$ 10,000,000,000
Treasury Shares Repurchased (in shares)						3.2	8.6
Payments for Repurchase of Common Stock						$ 300,000,000	$ 425,000,000		$ 7,190,000,000

Equity - Accumulated Other Comp

Equity - Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)	$ (312)
Other comprehensive income (loss) before reclassifications	74
Amount reclassified out of accumulated other comprehensive income (loss)	169
Tax effects	(65)
Other comprehensive income (loss)	178	$ 248	$ (562)
Accumulated other comprehensive income (loss)	(134)	(312)
Gains (Losses) on Derivative Instruments
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)	(304)
Other comprehensive income (loss) before reclassifications	34
Amount reclassified out of accumulated other comprehensive income (loss)	172
Tax effects	(64)
Other comprehensive income (loss)	142
Accumulated other comprehensive income (loss)	(162)	(304)
Unrealized Gains (Losses) on Investments
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)	(41)
Other comprehensive income (loss) before reclassifications	33
Amount reclassified out of accumulated other comprehensive income (loss)	0
Tax effects	0
Other comprehensive income (loss)	33
Accumulated other comprehensive income (loss)	(8)	(41)
Pension Liability Adjustments
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)	36
Other comprehensive income (loss) before reclassifications	7
Amount reclassified out of accumulated other comprehensive income (loss)	(3)
Tax effects	(1)
Other comprehensive income (loss)	3
Accumulated other comprehensive income (loss)	39	36
Cumulative Foreign Currency Translation Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)	(3)
Other comprehensive income (loss) before reclassifications	0
Amount reclassified out of accumulated other comprehensive income (loss)	0
Tax effects	0
Other comprehensive income (loss)	0
Accumulated other comprehensive income (loss)	$ (3)	$ (3)

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions	Aug. 29, 2024	Aug. 31, 2023
Fair Value
Fair Value of Notes Payable
Notes (level 2)	$ 11,316	$ 11,549
Carrying Value
Fair Value of Notes Payable
Notes (level 2)	$ 11,343	$ 12,049

Derivative Instruments - Notion

Derivative Instruments - Notional Amounts and Fair Values (Details) - USD ($) $ in Millions		12 Months Ended
		Aug. 29, 2024	Aug. 31, 2023
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1],[2]	$ 95	$ 63
Fair Value of Liabilities	[2],[3]	$ (182)	(297)
Designated hedging instruments | Cash flow hedges
Fair Value of Derivative Assets and Liabilities
General maturity of cash flow hedges (in years)		2 years
Designated hedging instruments | Cash flow hedges | Currency hedges
Notional Disclosures
Notional or Contractual Amount		$ 3,724	3,873
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1],[2]	57	16
Fair Value of Liabilities	[2],[3]	(71)	(180)
Designated hedging instruments | Cash flow hedges | Commodity hedges
Notional Disclosures
Notional or Contractual Amount		471	331
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1],[2]	20	45
Fair Value of Liabilities	[2],[3]	(7)	0
Designated hedging instruments | Fair value hedges | Currency hedges
Notional Disclosures
Notional or Contractual Amount		2,511
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1],[2]	0
Fair Value of Liabilities	[2],[3]	$ (41)
General maturity of cash flow hedges (in years)		1 year
Designated hedging instruments | Fair value hedges | Interest rate swap
Notional Disclosures
Notional or Contractual Amount		$ 900	900
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1],[2]	0	0
Fair Value of Liabilities	[2],[3]	(60)	(100)
Not designated hedging instruments | Currency hedges
Notional Disclosures
Notional or Contractual Amount		2,393	1,839
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1],[2]	18	2
Fair Value of Liabilities	[2],[3]	$ (3)	$ (17)
General maturity of currency forward contracts (in months)		3 months
[1] Included in receivables and other noncurrent assets. Included in accounts payable and accrued expenses and other noncurrent liabilities.

Derivative Instruments - Gain (

Derivative Instruments - Gain (Loss) on Derivatives (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Fair value hedges
Fair Value Hedges
Fair Value of Hedged Cash and Investments	$ 2,580
Designated hedging instruments | Cash flow hedges
Cash Flow Hedges
Net gains (losses) recognized in other comprehensive income (loss) from cash flow hedges	33	$ 30	$ (735)
Gain (loss) from components excluded from cash flow hedge effectiveness	(135)	(101)	(32)
Cash flow hedge gains (losses) reclassified from AOCI to earnings	(172)	$ (261)	(53)
Cash flow hedge (losses) expected to be reclassified into earnings within twelve months	$ (89)
Designated hedging instruments | Fair value hedges
Fair Value Hedges
Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge			96
Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments			$ (96)

Equity Plans - Share Based Info

Equity Plans - Share Based Information and Restricted Stock Awards (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future awards (in shares)	69
Restricted stock awards
Restricted Stock Awards Roll Forward (Shares)
Number of Shares - Outstanding	29
Number of Shares - Granted	13	17	13
Number of Shares - Vested	(12)
Number of Shares - Forfeited	(2)
Number of Shares - Outstanding	28	29
Restricted Stock Awards Roll Forward (Weighted Average Grant Date Fair Value)
Weighted Average Grant Date Fair Value Per Share - Outstanding	$ 59.11
Weighted Average Grant Date Fair Value Per Share - Granted	72.72	$ 55.99	$ 70.81
Weighted Average Grant Date Fair Value Per Share - Restrictions Vested	57.92
Weighted Average Grant Date Fair Value Per Share - Forfeited	60.42
Weighted Average Grant Date Fair Value Per Share - Outstanding	$ 65.82	$ 59.11
Aggregate vesting-date fair value of shares vested	$ 1,008	$ 514	$ 498
Performance and Market-based Restricted Stock Awards
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Restricted award vesting period	3 years
Performance and Market-based Restricted Stock Awards | Minimum
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Restricted award achievement potential, percentage	0%
Performance and Market-based Restricted Stock Awards | Maximum
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Restricted award achievement potential, percentage	200%
Service-based Restricted Stock Awards
Restricted Stock Awards Roll Forward (Shares)
Number of Shares - Outstanding	24
Service-based Restricted Stock Awards | Minimum | Tranche 1 - Initial vesting after one year
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Annual vesting rights, percentage	25%
Service-based Restricted Stock Awards | Minimum | Tranche 2 - Quarterly vesting for remaining term
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Annual vesting rights, percentage	6.25%
Service-based Restricted Stock Awards | Maximum | Tranche 1 - Initial vesting after one year
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Annual vesting rights, percentage	33%
Service-based Restricted Stock Awards | Maximum | Tranche 2 - Quarterly vesting for remaining term
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Annual vesting rights, percentage	8.33%
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future awards (in shares)	11
Restricted Stock Awards Roll Forward (Weighted Average Grant Date Fair Value)
Weighted Average Grant Date Fair Value Per Share - Granted	$ 26.82	$ 17.06	$ 18.87

Equity Plans - ESPP and Stock O

Equity Plans - ESPP and Stock Options (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Employee Stock Purchase Plan
Employee Stock Purchase Plan ("ESPP")
ESPP maximum payroll deduction percentage (in hundredths)	15%
ESPP percentage purchase price of common stock (in hundredths)	85%
Period from grant date until stock options expire or ESPP program period (in years or months)	6 months
ESPP shares purchased (in shares)	4	5	4
ESPP Fair Value Assumptions and Methodology
Share-Based Payment Arrangement, Valuation Technique [Extensible Enumeration]	Black-Scholes-Merton Model [Member]
Weighted-average grant-date fair value per share	$ 26.82	$ 17.06	$ 18.87
Average expected life in years	6 months	6 months	6 months
Weighted-average expected volatility (based on implied volatility)	41%	37%	43%
Weighted-average risk-free interest rate	5.20%	5.10%	2%
Expected dividend yield	0.50%	0.70%	0.60%
Employee Stock Purchase Plan | Weighted Average
Employee Stock Purchase Plan ("ESPP")
ESPP weighted average price of shares purchased	$ 65.72	$ 51.93	$ 58.52
Employee Stock Option
Stock Option Disclosures
Number of shares exercised (in shares)	1.3
Total intrinsic value for option exercised	$ 92	$ 30	$ 54

Equity Plans - Stock-based comp

Equity Plans - Stock-based compensation expense (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 821	$ 557	$ 496
Equity Plans, Additional Disclosures
Tax benefit from compensation expense	140	68	77
Total unrecognized compensation costs related to non-vested awards expected to be recognized	$ 1,440
Weighted average period that unrecognized compensation costs is expected to be recognized (in years)	1 year 2 months 12 days
Restricted stock awards
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 749	488	429
Employee Stock Purchase Plan
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	72	69	66
Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	0	0	1
Equity plans
Equity Plans, Additional Disclosures
Expense capitalized and remained in inventory	99	88
Cost of goods sold
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	312	201	193
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	296	226	175
Selling, general, and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	213	137	133
Restructure
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 0	$ (7)	$ (5)

Employee Benefit Plans - (Detai

Employee Benefit Plans - (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Employee Savings Plan for U.S. Employees
Maximum annual contributions per employee (in hundredths)	75%
Employer matching contribution, percent of employees' eligible earnings (in hundredths)	5%
Defined contribution plan contribution expense	$ 66	$ 59	$ 66
Retirement Plans
Projected pension benefit obligation	191	175
Pension plan assets	$ 261	$ 232

Government Incentives (Details)

Government Incentives (Details) $ in Millions, ₨ in Billions, ¥ in Billions	12 Months Ended
	Aug. 29, 2024 USD ($)	Aug. 29, 2024 INR (₨)	Aug. 29, 2024 JPY (¥)	Aug. 31, 2023 USD ($)
Balance Sheet Line Items Effected by Government Assistance
Government Assistance, Asset, Current, Statement of Financial Position [Extensible Enumeration]	Receivables	Receivables	Receivables
Current Government Assistance Assets (included in Receivables)	$ 834
Government Assistance, Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other noncurrent assets	Other noncurrent assets	Other noncurrent assets
Noncurrent Government Assistance Assets (included in Other noncurrent assets)	$ 188
Noncurrent unearned government incentives	550			$ 727
Government Assistance, Income Statement Benefit
Government Assistance, Operating Expense, Decrease	$ 588
Government Assistance, Operating Expense, Decrease (Increase), Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of goods sold, Research and development
Capital Expenditure Related Grant
Government Assistance, Asset
Government Assistance, Asset, Decrease, Noncurrent, Cumulative	$ 2,340
Government Assistance, Asset, Decrease
Government Assistance, Asset, Decrease, Noncurrent	$ 1,100
Government Assistance, Asset, Decrease, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization
Project Related Grant
Balance Sheet Line Items Effected by Government Assistance
Government Assistance, Award Amount	$ 3,400
Project_New York Fabrication Facility
Balance Sheet Line Items Effected by Government Assistance
Government Assistance, Nonbinding Commitment Amount	5,500
Project_Gujarat India Assembly and Test Facility
Balance Sheet Line Items Effected by Government Assistance
Government Assistance, Award Amount	$ 1,800	₨ 150
India Central Government Funding
Balance Sheet Line Items Effected by Government Assistance
Government Assistance, Award Percentage	50%	50%	50%
Gujarat State Funding
Balance Sheet Line Items Effected by Government Assistance
Government Assistance, Award Percentage	20%	20%	20%
Project_Hiroshima Japan DRAM EUV
Balance Sheet Line Items Effected by Government Assistance
Government Assistance, Award Amount	$ 1,300		¥ 188
CHIPS Investment Tax Credit
Balance Sheet Line Items Effected by Government Assistance
Government Assistance, Award Percentage	25%	25%	25%
CHIPS Direct Funding
Balance Sheet Line Items Effected by Government Assistance
Government Assistance, Nonbinding Commitment Amount	$ 6,100
CHIPS Federal Loans
Balance Sheet Line Items Effected by Government Assistance
Government Assistance, Nonbinding Commitment Amount	$ 7,500
Cost of goods sold
Government Assistance, Income Statement Benefit
Government Incentives, Income Statement benefit by caption, Percentage	85%
Research and development
Government Assistance, Income Statement Benefit
Government Incentives, Income Statement benefit by caption, Percentage	15%
Minimum
Government Assistance [Line Items]
Government Incentives, Initial term	1 year
Maximum
Government Assistance [Line Items]
Government Incentives, Initial term	15 years

Revenue and Customer Contract_3

Revenue and Customer Contract Liabilities (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 25,111	$ 15,540	$ 30,758
Contract liabilities	907
Contract with Customer, Liability, Current	766
Estimated consideration payable to customers for pricing adjustments and returns	718	453
Proceeds from Insurance Settlement, Operating Activities		228
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-08-29
Disaggregation of Revenue [Line Items]
Amount of Remaining Performance Obligation	$ (141)
Expected timing of satisfaction of remaining performance obligation
Business Interruption Proceeds
Disaggregation of Revenue [Line Items]
Revenue		186
DRAM
Disaggregation of Revenue [Line Items]
Revenue	$ 17,603	10,978	22,386
NAND
Disaggregation of Revenue [Line Items]
Revenue	7,227	4,206	7,811
Other (primarily NOR)
Disaggregation of Revenue [Line Items]
Revenue	$ 281	$ 356	$ 561

Restructure and Asset Impairm_3

Restructure and Asset Impairments (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Dec. 31, 2023	Aug. 31, 2023	Sep. 01, 2022
Restructuring and Related Activities [Abstract]
Employee severance	$ 1		$ 163	$ 0
Asset impairments and other asset-related costs	0		14	63
Other	0		(6)	(15)
Restructure and asset impairments	$ 1		$ 171	$ 48
Restructure headcount reduction (in hundredths)		15%

Other Operating (Income) Expe_3

Other Operating (Income) Expense, Net (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Other Income and Expenses [Abstract]
Patent cross-license agreement gain	$ (200)	$ 0	$ 0
(Gain) loss on disposition of property, plant, and equipment	(59)	(54)	(41)
Goodwill impairment	0	101	0
Litigation settlement	0	68	0
Other	8	9	7
Other operating (income) expense, net	(251)	124	(34)
Segment Reporting Information [Line Items]
Goodwill impairment	$ 0	101	$ 0
SBU
Other Income and Expenses [Abstract]
Goodwill impairment		101
Segment Reporting Information [Line Items]
Goodwill impairment		$ 101

Income Taxes - Income (loss) be

Income Taxes - Income (loss) before Taxes and Other Items (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Income (loss) before income taxes and equity in net income (loss) of equity method investees
U.S.	$ 544	$ 235	$ 112
Foreign	696	(5,893)	9,459
Income (loss) before income taxes and equity in net income (loss) of equity method investees	1,240	(5,658)	9,571
Current
U.S. federal	(82)	(5)	(65)
State	(1)	(1)	(1)
Foreign	(333)	(178)	(528)
Total income tax (provision) benefit - current	(416)	(184)	(594)
Deferred
U.S. federal	18	(84)	(166)
State	0	0	(225)
Foreign	(53)	91	97
Total income tax (provision) benefit - deferred	(35)	7	(294)
Income tax (provision) benefit	$ (451)	$ (177)	$ (888)

Income Taxes - Effective Income

Income Taxes - Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Effective Income Tax Rate Reconciliation, Amount
U.S. federal income tax (provision) benefit at statutory rate	$ (260)	$ 1,188	$ (2,010)
U.S. tax on foreign operations	(7)	6	(322)
Change in valuation allowance	(59)	(50)	(241)
Change in unrecognized tax benefits	(41)	(30)	(67)
Foreign tax rate differential	(214)	(1,285)	1,601
Research and development tax credits	76	43	66
State taxes, net of federal benefit	12	37	0
Other	42	(86)	85
Income tax (provision) benefit	$ (451)	$ (177)	$ (888)
Effective Income Tax Rate Reconciliation, Percent
U.S. federal statutory rate (percent)	21%	21%	21%
U.S. tax on foreign operations (percent)	0.60%	0.10%	3.40%
Change in valuation allowance (percent)	4.80%	(0.90%)	2.50%
Change in unrecognized tax benefits (percent)	3.30%	(0.50%)	0.70%
Foreign tax rate differential (percent)	17.20%	(22.80%)	(16.70%)
Research and development tax credits (percent)	(6.10%)	0.80%	(0.70%)
State taxes, net of federal benefit (percent)	(1.00%)	0.70%	0%
Other (percent)	(3.40%)	(1.50%)	(0.90%)
Effective tax rate (percent)	36.40%	(3.10%)	9.30%

Income Taxes - Tax Holiday and

Income Taxes - Tax Holiday and Other (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Sep. 01, 2022	Aug. 29, 2024
Income Tax Disclosure [Abstract]
Tax benefit from incentive arrangements	$ 1,120
Tax benefit per diluted share from incentive arrangements	$ 1
Undistributed earnings of foreign subsidiaries deemed indefinitely reinvested		$ 4,120

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Aug. 29, 2024	Aug. 31, 2023
Deferred tax assets
Net operating loss and tax credit carryforwards	$ 1,050	$ 1,112
Accrued salaries, wages, and benefits	182	39
Operating lease liabilities	175	135
Inventories	4	52
Other	59	75
Gross deferred tax assets	1,470	1,413
Less valuation allowance	(593)	(528)
Deferred tax assets, net of valuation allowance	877	885
Deferred tax liabilities
Right-of-use assets	(152)	(115)
Property, plant, and equipment	(194)	(31)
Other	(70)	(100)
Deferred tax liabilities	(416)	(246)
Net deferred tax assets	461	639
Reported as
Deferred tax assets	520	756
Deferred tax liabilities (included in other noncurrent liabilities)	$ (59)	$ (117)

Income Taxes - Operating Loss C

Income Taxes - Operating Loss Carryforwards (Details) $ in Millions	Aug. 29, 2024 USD ($)
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 3,311
2025 - 2029
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	194
2030 - 2034
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	749
2035 - 2039
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	285
2040 - 2044
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	94
Indefinite
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	1,989
State
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	724
State | 2025 - 2029
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	47
State | 2030 - 2034
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	298
State | 2035 - 2039
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	285
State | 2040 - 2044
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	94
State | Indefinite
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Malaysia
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	1,224
Malaysia | 2025 - 2029
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Malaysia | 2030 - 2034
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Malaysia | 2035 - 2039
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Malaysia | 2040 - 2044
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Malaysia | Indefinite
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	1,224
Singapore
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	765
Singapore | 2025 - 2029
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Singapore | 2030 - 2034
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Singapore | 2035 - 2039
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Singapore | 2040 - 2044
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Singapore | Indefinite
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	765
Japan
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	469
Japan | 2025 - 2029
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	144
Japan | 2030 - 2034
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	325
Japan | 2035 - 2039
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Japan | 2040 - 2044
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Japan | Indefinite
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Other
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	129
Other | 2025 - 2029
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	3
Other | 2030 - 2034
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	126
Other | 2035 - 2039
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Other | 2040 - 2044
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Other | Indefinite
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 0

Income Taxes - Tax Credit Carry

Income Taxes - Tax Credit Carryforwards (Details) $ in Millions	Aug. 29, 2024 USD ($)
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	$ 942
2025 - 2029
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	61
2030 - 2034
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	183
2035 - 2039
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	232
2040 - 2044
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	321
Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	145
U.S. Federal
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	410
U.S. Federal | 2025 - 2029
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
U.S. Federal | 2030 - 2034
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	47
U.S. Federal | 2035 - 2039
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	48
U.S. Federal | 2040 - 2044
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	315
U.S. Federal | Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
State
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	486
State | 2025 - 2029
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	61
State | 2030 - 2034
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	134
State | 2035 - 2039
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	140
State | 2040 - 2044
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	6
State | Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	145
Other
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	46
Other | 2025 - 2029
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
Other | 2030 - 2034
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	2
Other | 2035 - 2039
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	44
Other | 2040 - 2044
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
Other | Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	$ 0

Income Taxes - Unrecognized Tax

Income Taxes - Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Unrecognized Tax Benefits Roll Forward
Beginning unrecognized tax benefits	$ 744	$ 731	$ 660
Increases related to tax positions from prior years	2	2	14
Increases related to prior year tax positions taken in current year	20	27	0
Increases related to tax positions taken in current year	54	17	80
Decreases related to tax positions from prior years	(89)	(33)	(23)
Decreases related to settlement with tax authorities	(15)	0	0
Ending unrecognized tax benefits	716	$ 744	$ 731
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	$ 633
Internal Revenue Service (IRS)
Income Tax Contingency [Line Items]
Tax years under audit	2018 2019
U.S. Federal
Income Tax Contingency [Line Items]
Tax years open to examination	2018 2019 2020 2021 2022 2023 2024
State
Income Tax Contingency [Line Items]
Tax years open to examination	2018 2019 2020 2021 2022 2023 2024
Foreign
Income Tax Contingency [Line Items]
Tax years open to examination	2016 2017 2018 2019 2020 2021 2022 2023 2024

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Earnings Per Share Reconciliation
Net income (loss) - Basic	$ 778	$ (5,833)	$ 8,687
Net income (loss) - Diluted	$ 778	$ (5,833)	$ 8,687
Weighted Average Number of Shares Outstanding Reconciliation
Weighted-average common shares outstanding – Basic	1,105	1,093	1,112
Dilutive effect of equity compensation plans	13	0	10
Weighted-average common shares outstanding – Diluted	1,118	1,093	1,122
Basic (in dollars per share)	$ 0.70	$ (5.34)	$ 7.81
Diluted (in dollars per share)	$ 0.70	$ (5.34)	$ 7.75
Antidilutive potential common shares that could dilute basic earnings per share in the future (in shares)	3	33	5

Segment and Other Information_2

Segment and Other Information (Details) $ in Millions	12 Months Ended
	Aug. 29, 2024 USD ($) segment	Aug. 31, 2023 USD ($)	Sep. 01, 2022 USD ($)
Reportable Segments
Number of reportable segments | segment	4
Goodwill
Goodwill	$ 1,150	$ 1,150
Net sales
Revenue	25,111	15,540	$ 30,758
Operating income (loss)
Patent cross-license agreement	200	0	0
Stock-based compensation	(821)	(557)	(496)
Restructure and asset impairment	(1)	(171)	(48)
Provision to write down inventories to net realizable value	0	(1,831)	0
Goodwill impairment	0	(101)	0
Litigation settlement	0	(68)	0
Operating income (loss)	1,304	(5,745)	9,702
Depreciation and amortization
Depreciation and amortization expense by segment	7,780	7,756	7,116
Operating Segments
Operating income (loss)
Operating income (loss)	948	(3,832)	10,281
Unallocated
Operating income (loss)
Lower costs from sale of inventory written down in prior periods	987	844	0
Patent cross-license agreement	200	0	0
Stock-based compensation	(821)	(564)	(501)
Restructure and asset impairment	(1)	(171)	(48)
Provision to write down inventories to net realizable value	0	(1,831)	0
Goodwill impairment	0	(101)	0
Litigation settlement	0	(68)	0
Other	(9)	(22)	(30)
Operating income (loss)	356	(1,913)	(579)
Depreciation and amortization
Depreciation and amortization expense by segment	18	19	20
CNBU
Goodwill
Goodwill	855
Net sales
Revenue	9,513	5,710	13,693
CNBU | Operating Segments
Operating income (loss)
Operating income (loss)	980	(585)	5,844
Depreciation and amortization
Depreciation and amortization expense by segment	2,760	2,512	2,766
MBU
Goodwill
Goodwill	198
Net sales
Revenue	6,354	3,630	7,260
MBU | Operating Segments
Operating income (loss)
Operating income (loss)	114	(1,750)	2,160
Depreciation and amortization
Depreciation and amortization expense by segment	2,002	2,149	1,725
EBU
Goodwill
Goodwill	97
Net sales
Revenue	4,614	3,637	5,235
EBU | Operating Segments
Operating income (loss)
Operating income (loss)	199	382	1,752
Depreciation and amortization
Depreciation and amortization expense by segment	1,491	1,324	1,280
SBU
Net sales
Revenue	4,592	2,553	4,553
SBU | Operating Segments
Operating income (loss)
Operating income (loss)	(362)	(1,887)	513
Depreciation and amortization
Depreciation and amortization expense by segment	1,501	1,751	1,323
All Other
Net sales
Revenue	38	10	17
All Other | Operating Segments
Operating income (loss)
Operating income (loss)	17	8	12
Depreciation and amortization
Depreciation and amortization expense by segment	$ 8	$ 1	$ 2

Certain Concentrations (Details

Certain Concentrations (Details) - Revenue from Contract with Customer	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Product Concentration Risk | Data center and networking
Concentration Risk [Line Items]
Concentration Risk, Percentage	35%	25%	35%
Product Concentration Risk | Mobile
Concentration Risk [Line Items]
Concentration Risk, Percentage	25%	25%	25%
Product Concentration Risk | PC, graphics, and other
Concentration Risk [Line Items]
Concentration Risk, Percentage	25%	30%	25%
Product Concentration Risk | Intelligent edge – automotive, industrial, and consumer embedded
Concentration Risk [Line Items]
Concentration Risk, Percentage	20%	25%	15%
Customer Concentration Risk | Undisclosed Customer 1
Concentration Risk [Line Items]
Concentration Risk, Percentage	10%		12%
Customer Concentration Risk | Undisclosed Customer 2
Concentration Risk [Line Items]
Concentration Risk, Percentage			11%

Geographic Information (Details

Geographic Information (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Revenue by Geographic Location of Customers' Headquarters
Revenue	$ 25,111	$ 15,540	$ 30,758
Long-Lived Assets by Geographic Location
Long-lived assets	40,394	38,594
United States
Revenue by Geographic Location of Customers' Headquarters
Revenue	13,168	7,805	16,026
Long-Lived Assets by Geographic Location
Long-lived assets	6,508	5,196
Taiwan
Revenue by Geographic Location of Customers' Headquarters
Revenue	4,708	2,697	6,185
Long-Lived Assets by Geographic Location
Long-lived assets	14,156	12,926
Mainland China (excluding Hong Kong)
Revenue by Geographic Location of Customers' Headquarters
Revenue	3,045	2,181	3,311
Long-Lived Assets by Geographic Location
Long-lived assets	486	395
Other Asia Pacific
Revenue by Geographic Location of Customers' Headquarters
Revenue	1,330	752	1,223
Hong Kong
Revenue by Geographic Location of Customers' Headquarters
Revenue	1,071	340	1,665
Japan
Revenue by Geographic Location of Customers' Headquarters
Revenue	840	987	1,696
Long-Lived Assets by Geographic Location
Long-lived assets	7,085	7,323
Europe
Revenue by Geographic Location of Customers' Headquarters
Revenue	818	682	505
Other
Revenue by Geographic Location of Customers' Headquarters
Revenue	131	96	$ 147
Long-Lived Assets by Geographic Location
Long-lived assets	80	70
Singapore
Long-Lived Assets by Geographic Location
Long-lived assets	10,588	11,283
Malaysia
Long-Lived Assets by Geographic Location
Long-lived assets	1,153	1,124
India
Long-Lived Assets by Geographic Location
Long-lived assets	$ 338	$ 277

Schedule II Valuation and Qua_3

Schedule II Valuation and Qualifying Accounts (Details) - Deferred Tax Assets Valuation Allowance - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2024	Aug. 31, 2023	Sep. 01, 2022
Deferred Tax Asset Valuation Allowance Roll Forward
Balance at Beginning of Year	$ 528	$ 471	$ 233
Charged to Income Tax Provision	57	58	241
Currency Translation and Charges to Other Accounts	8	(1)	(3)
Balance at End of Year	$ 593	$ 528	$ 471